rfhg_1220.1

Basic information about the TSS

---

TSS ID: rfhg_1220.1 Species: human Chr: chr1		Start: 8877699 End: 8877749 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Transcript_name: ENST00000414948.1 Distance: -258 GeneID: 2023 HGNC/MGI_ID: HGNC:3350 UniProt_ID:

Gene_name: ENO1 Gene_symbol: ENO1 Gene_synonyms: MBP-1 PPH Gene_source: HGNC:3350

TATA-Box annotation

---

Distance to TSS:	962
Nearest PromoterID:	NM_001353346
Entrez ID:	2023
Nearest Unigene:	Hs.517145
Nearest Refseq:	NM_001428
Nearest Ensembl:	ENSG00000074800
Gene Name:	ENO1
Gene Alias:	ENO1L1|HEL-S-17|MPB1|NNE|PPH
Gene Description:	enolase 1
Gene Type:	protein-coding
CpG%:	0.060000
GC%:	0.431373
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ENO1 p2@ENO1 p3@ENO1 p4@ENO1 p5@ENO1 p8@ENO1 p9@ENO1 p10@ENO1
Sample		p1@ENO1	p2@ENO1	p3@ENO1	p4@ENO1	p5@ENO1	p8@ENO1	p9@ENO1	p10@ENO1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1233.11	70.52	80.65	3.51	3.70	9.16	6.04	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1301.72	61.10	86.79	3.84	4.45	5.46	5.06	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1323.32	63.47	94.72	4.05	3.47	5.79	5.59	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1349.13	58.63	97.93	3.74	4.37	7.90	5.82	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1421.79	69.51	94.04	3.60	5.40	5.40	4.72	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1336.13	63.38	97.87	3.10	4.26	4.65	5.04	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1962.69	108.72	161.45	4.79	3.92	6.54	9.37	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1555.53	73.39	112.87	5.33	3.39	6.78	6.30	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1584.28	74.37	116.05	3.42	5.13	9.40	7.05	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1097.81	64.34	104.33	2.90	8.11	6.96	4.06	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1075.26	50.13	109.95	2.43	4.45	4.85	3.64	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	926.94	43.09	101.64	0.81	4.47	2.44	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	838.20	64.64	93.33	1.93	1.13	2.90	3.39	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	905.71	61.19	99.53	3.46	0.45	3.91	6.31	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	961.64	58.84	95.94	1.32	0.22	3.95	4.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	804.27	44.01	91.54	3.02	0.25	7.54	5.03	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	821.65	50.45	96.75	1.31	0.87	3.71	5.24	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	736.49	49.35	83.10	4.22	1.27	5.48	5.91	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	809.33	40.52	112.50	2.67	1.60	3.20	3.20	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	926.87	59.42	102.00	3.16	1.96	5.57	6.92	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	890.52	64.55	103.71	1.47	1.60	4.41	4.01	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	953.23	62.49	111.17	2.24	0.69	3.97	5.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	853.87	51.44	102.63	2.59	1.16	4.65	2.84	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	874.33	54.36	99.25	3.88	1.21	6.55	4.13	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	867.10	59.85	100.36	3.35	0.52	4.90	7.22	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	992.27	59.19	123.76	3.48	1.58	3.80	6.65	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	882.43	54.95	108.79	1.65	3.30	7.14	6.59	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	991.81	76.38	98.78	3.06	0.94	5.89	4.24	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	871.26	62.83	95.14	2.91	1.45	5.17	5.65	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	913.70	59.36	100.44	3.08	0.18	4.16	4.52	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	948.75	56.31	94.20	4.81	1.67	3.35	3.35	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	945.65	63.11	93.98	4.10	1.56	2.74	5.08	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	842.22	48.11	89.05	3.38	0.63	2.74	5.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1349.21	78.51	155.04	2.64	0.49	4.29	6.10	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	926.72	60.77	101.91	4.67	0.37	3.93	5.80	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	811.72	60.17	78.95	3.83	0.57	4.98	4.79	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	936.47	69.90	92.58	3.27	2.04	4.91	5.93	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	883.72	53.19	89.46	3.22	0.20	4.23	4.84	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1026.12	68.88	107.23	2.70	0.00	2.97	3.24	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	973.45	55.93	98.67	1.68	0.24	3.60	4.56	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	838.23	54.11	95.28	1.88	0.94	3.53	3.53	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1098.10	61.49	118.29	1.46	0.88	2.93	2.78	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	832.40	56.73	74.02	3.37	0.84	2.32	3.37	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	862.07	57.87	81.64	2.62	0.70	2.27	2.10	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1035.59	69.47	94.36	4.22	0.80	4.02	3.01	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	996.42	72.35	98.87	5.58	0.23	5.12	6.05	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	772.02	58.30	76.05	2.64	0.48	2.64	2.64	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1023.21	67.96	88.22	1.19	0.60	2.68	2.38	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	835.89	56.49	80.67	2.15	0.72	1.68	3.59	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	866.82	55.20	84.92	1.42	1.01	1.01	2.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	756.89	56.16	84.44	7.17	0.82	2.66	4.10	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	704.70	53.37	80.28	2.22	1.78	4.89	4.23	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	6142.57	321.82	349.80	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	572.39	44.00	61.39	3.19	0.00	2.48	5.32	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	621.35	39.43	51.70	1.99	0.99	5.30	4.31	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2682.92	134.23	161.91	10.91	0.84	4.19	4.19	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1384.16	64.75	131.80	5.51	1.84	4.59	7.81	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	550.01	41.16	52.51	2.27	0.32	4.21	4.86	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	504.24	40.15	51.07	0.96	0.32	1.28	2.57	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1096.70	62.87	91.47	7.54	0.00	5.97	4.40	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	528.09	28.20	45.83	2.12	0.00	2.82	4.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	520.41	37.01	47.11	1.12	0.56	2.80	3.93	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1090.72	48.56	58.91	6.37	0.00	0.80	0.80	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	729.14	43.49	53.00	3.74	0.68	2.04	2.72	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	361.64	32.17	24.69	2.60	0.97	0.32	2.27	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	399.00	28.40	27.69	2.13	0.71	3.55	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	4089.48	80.82	64.66	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	3869.77	181.64	63.18	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	534.80	31.20	28.28	0.98	0.98	0.98	4.39	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	573.23	32.23	29.75	2.98	0.00	1.49	3.47	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	578.89	32.37	25.33	2.35	1.41	2.35	2.35	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	581.24	38.09	30.80	3.97	0.99	2.98	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	477.31	37.74	26.29	2.78	0.93	7.11	2.78	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	457.09	33.33	22.01	0.92	0.31	7.03	1.83	1.22
Adipocyte - breast, donor1	11376-118A8	1194.37	52.90	58.29	1.74	1.11	0.63	0.79	0.95
Adipocyte - breast, donor2	11327-117E4	905.61	37.70	50.37	8.98	0.64	2.09	1.93	0.64
Adipocyte - omental, donor1	11473-119C6	1048.74	54.84	53.82	1.65	2.29	0.76	0.64	0.51
Adipocyte - omental, donor2	11474-119C7	815.51	34.38	43.35	5.98	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	546.92	26.79	25.45	3.35	0.67	1.00	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	1192.40	38.28	89.96	7.66	0.64	3.19	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	514.57	34.08	26.39	2.20	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1478.17	70.45	89.42	3.16	0.45	1.35	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	349.64	33.19	13.90	1.74	0.87	0.87	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	567.75	47.72	17.41	0.39	0.59	0.39	1.17	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	503.43	36.81	18.53	2.06	0.26	0.51	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	688.01	38.19	22.86	1.12	1.67	0.84	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	368.56	31.15	5.88	0.59	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	839.96	56.79	19.46	1.13	1.77	0.40	0.56	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	513.18	28.08	14.52	0.97	0.00	0.97	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	443.61	23.46	11.73	2.67	1.60	2.13	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	604.85	35.61	11.13	1.11	1.11	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	534.01	40.34	17.05	0.42	2.91	1.66	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	588.73	31.90	20.09	1.26	1.26	0.75	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	532.43	30.43	13.09	0.98	1.96	0.65	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	414.39	22.23	13.70	1.83	0.91	0.30	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	3380.16	188.07	194.48	3.09	1.33	1.10	2.21	3.76
Alveolar Epithelial Cells, donor2	11590-120G6	3011.37	90.36	174.63	8.96	2.87	2.15	2.51	7.53
Alveolar Epithelial Cells, donor3	11671-122G6	2201.95	125.79	206.06	4.79	0.00	1.20	2.40	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	1093.65	96.79	38.14	0.90	0.72	0.90	0.90	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	748.05	51.88	40.16	3.35	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	530.05	66.56	18.90	1.23	1.03	0.21	0.21	1.23
Anulus Pulposus Cell, donor1	11248-116E6	1217.95	100.69	80.21	1.83	1.14	1.26	0.69	0.23
Anulus Pulposus Cell, donor2	11463-119B5	774.40	51.19	63.19	3.67	0.00	0.98	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	502.31	25.61	34.15	6.29	0.00	0.45	2.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	498.83	37.77	36.47	5.21	0.00	1.30	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	601.41	51.37	44.95	6.42	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	518.93	34.08	36.47	5.08	0.00	0.90	1.49	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	576.68	41.73	37.94	6.32	0.00	0.00	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	470.63	40.92	25.08	3.30	0.00	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	458.41	33.79	32.49	4.55	0.65	0.97	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	498.06	39.32	31.55	1.94	0.97	2.91	0.49	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	530.33	38.60	39.20	5.94	0.59	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	504.32	33.14	43.69	4.90	0.38	0.75	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	419.44	29.75	35.56	2.90	0.73	2.18	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	466.40	33.85	27.58	3.76	0.00	2.51	2.51	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	667.35	59.63	38.22	0.33	0.82	0.99	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	459.94	23.20	43.67	2.73	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	630.61	50.67	36.79	0.75	0.30	1.06	0.60	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	439.88	34.29	39.11	1.61	0.54	1.07	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	465.35	47.61	31.55	4.16	0.57	0.38	0.94	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	476.84	38.76	36.62	2.14	0.53	1.34	0.80	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	344.33	28.29	28.29	3.90	0.00	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	493.10	38.48	26.54	1.66	1.16	0.83	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	501.90	39.62	30.02	0.00	1.20	2.40	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	361.10	31.86	42.48	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	415.79	31.90	22.47	1.72	0.51	0.86	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	432.08	25.17	54.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	497.08	28.64	36.41	4.37	0.49	0.49	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	558.17	46.29	37.19	3.79	1.14	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	433.67	42.40	26.65	3.63	1.21	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	472.56	34.20	31.35	3.99	0.57	1.14	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	393.13	36.56	25.87	1.50	0.64	0.86	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	385.33	33.55	31.49	1.55	0.00	0.52	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	492.67	29.56	35.19	3.75	0.47	1.41	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	411.58	33.44	32.15	2.25	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	499.42	39.95	36.39	4.28	0.71	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	449.83	32.76	35.68	1.75	0.58	1.75	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	501.89	40.04	30.11	3.01	0.00	0.30	0.90	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	560.73	47.52	26.14	8.32	1.19	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	636.72	38.65	36.62	5.09	0.51	0.51	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	606.67	46.61	39.48	5.35	0.00	3.31	1.78	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	497.49	41.30	37.49	3.81	0.00	1.27	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	466.06	28.48	25.03	3.45	0.43	0.00	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	546.79	38.32	34.50	2.33	0.64	1.06	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	447.73	32.77	31.03	1.45	0.00	1.45	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	425.13	32.12	39.68	0.00	0.00	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	473.99	42.89	25.09	1.70	1.02	0.68	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	521.18	53.28	37.06	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	445.75	25.35	38.03	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	442.55	29.59	25.94	2.57	0.21	0.21	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	510.21	46.33	39.71	1.20	0.00	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	497.89	27.70	43.01	6.56	0.73	1.46	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	541.37	40.00	29.19	4.14	0.46	0.69	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	563.62	45.91	53.56	7.65	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	640.66	48.30	42.97	0.51	0.51	0.25	0.51	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	479.97	39.22	29.73	2.27	0.41	2.06	1.03	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	434.21	32.44	31.21	2.14	0.61	1.84	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	522.47	27.72	37.76	4.30	0.96	0.48	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	422.86	41.69	23.95	2.44	0.00	0.89	0.44	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	404.34	38.14	25.94	3.05	3.05	6.10	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	438.68	31.02	28.25	1.11	0.00	0.55	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	424.20	33.10	26.48	0.79	0.53	0.53	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	411.42	32.71	32.35	2.54	0.36	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	2685.75	177.59	100.71	1.23	0.86	0.61	0.61	2.82
Astrocyte - cerebellum, donor2	11580-120F5	1407.45	118.96	62.30	4.45	0.86	0.68	0.86	2.91
Astrocyte - cerebellum, donor3	11661-122F5	1245.06	84.74	61.25	3.36	0.84	0.84	1.05	1.68
Astrocyte - cerebral cortex, donor1	11235-116D2	1269.20	104.92	28.58	2.09	0.70	0.35	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	1572.28	126.51	51.77	9.54	0.32	1.62	2.10	8.74
Astrocyte - cerebral cortex, donor3	11392-118C6	1168.97	94.42	26.85	5.52	1.19	0.30	1.49	2.98
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2218.36	170.54	170.77	14.57	1.61	1.26	3.10	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1892.13	170.26	123.28	7.27	1.38	0.50	1.63	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1943.19	170.92	144.98	8.08	1.02	1.59	2.50	1.14
Basophils, donor1	12241-129G9	644.16	58.58	14.65	0.52	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	591.34	57.73	22.01	0.00	0.72	0.00	0.36	0.00
Basophils, donor3	12243-129H2	532.57	47.48	16.17	0.59	0.88	0.29	0.00	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	1689.68	98.53	126.99	2.80	1.08	0.65	0.65	2.37
Bronchial Epithelial Cell, donor2	11591-120G7	1738.22	109.27	164.13	4.57	0.46	1.37	0.91	4.57
Bronchial Epithelial Cell, donor3	11672-122G7	738.88	86.08	114.78	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2430.27	156.91	156.29	17.57	1.88	2.51	3.77	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	2778.84	160.54	202.13	15.39	1.25	0.62	1.25	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	1096.64	92.35	113.07	7.60	1.84	1.84	0.46	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	759.91	63.16	57.22	5.22	0.18	1.08	0.54	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	800.43	72.04	34.01	0.62	1.13	0.31	0.31	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4137.54	295.32	268.77	3.96	0.93	2.56	0.70	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1990.60	130.15	74.83	1.60	0.64	0.32	0.32	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	3216.34	124.10	175.81	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	460.99	40.58	15.22	0.00	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	237.20	19.49	10.21	1.48	0.19	0.19	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	232.49	23.27	9.66	1.10	0.88	0.00	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	683.83	50.66	13.02	2.55	1.13	0.28	0.28	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	701.29	35.63	17.44	1.14	1.14	2.27	0.76	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	547.68	41.75	10.19	0.66	0.00	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	741.25	35.56	24.14	3.61	1.01	0.29	0.72	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	571.80	28.06	21.42	1.81	2.41	0.91	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	612.60	32.22	18.24	3.08	0.95	0.00	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	551.24	29.13	17.41	1.51	1.17	0.50	0.67	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	450.45	15.46	18.22	2.21	0.55	0.83	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	565.28	24.05	16.12	0.74	0.99	0.25	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	481.87	30.94	15.47	2.15	0.98	0.59	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	425.54	25.28	11.93	1.07	0.89	0.53	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	793.92	42.00	23.72	1.31	1.52	1.09	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	451.86	23.18	15.92	0.94	0.47	0.70	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	382.82	24.29	12.14	1.58	0.00	0.00	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	505.87	29.95	18.86	2.22	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	592.47	29.90	21.57	2.38	0.45	0.74	1.04	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	643.94	28.93	21.35	1.80	0.80	0.80	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	981.24	43.93	29.15	2.50	1.25	0.83	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	639.68	36.38	21.51	2.75	0.23	1.14	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	647.17	27.14	19.00	0.45	0.90	0.23	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	431.22	20.95	15.71	1.31	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	579.67	32.82	20.71	2.96	1.08	0.81	0.00	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	528.27	31.93	16.05	1.57	0.52	0.00	1.05	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	557.59	29.04	16.41	2.52	1.68	0.42	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	542.68	30.31	18.19	1.84	0.37	0.55	1.29	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	461.82	19.37	15.15	0.35	0.35	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	508.04	20.18	14.04	0.44	0.00	0.44	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	434.19	25.28	15.52	2.44	0.52	0.70	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	399.18	28.99	14.87	1.12	0.74	0.00	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	783.09	49.79	20.26	1.72	1.51	0.43	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	521.28	32.76	22.52	0.00	0.00	1.64	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	616.82	28.97	17.38	0.46	0.23	0.23	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	697.37	35.73	20.42	2.32	0.93	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	685.50	51.66	14.17	1.09	0.87	0.00	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	689.52	42.27	19.63	1.15	0.46	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	661.11	51.12	16.90	0.22	1.73	0.43	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	978.87	79.42	19.93	1.40	1.40	0.00	0.93	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	829.74	58.86	20.78	0.87	0.70	1.05	1.05	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	742.93	47.27	18.51	0.89	0.22	0.22	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	630.79	52.06	13.01	0.51	2.55	0.00	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	625.98	42.60	14.05	1.54	1.32	1.54	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	699.64	47.16	16.00	0.21	0.63	0.21	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	353.62	50.81	10.16	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	394.58	52.20	11.53	1.36	0.68	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	368.67	59.03	6.21	0.00	3.11	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	413.10	54.90	7.46	0.53	2.67	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	436.90	78.27	8.04	1.07	1.61	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	375.54	59.66	9.13	0.70	2.11	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	429.83	43.92	5.49	0.00	0.78	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	479.86	67.23	2.64	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	129.86	18.90	4.93	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	116.79	13.06	5.80	2.18	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	117.62	17.67	5.05	0.00	0.00	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	84.04	18.99	2.02	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	87.09	19.18	1.60	0.00	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	553.23	34.14	52.21	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	739.34	48.88	73.04	1.69	0.00	1.69	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1351.97	120.99	49.98	1.88	0.38	0.38	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1595.52	140.25	61.11	0.45	1.13	0.68	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	201.38	24.99	7.86	0.00	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	167.18	16.53	16.53	0.61	0.61	0.00	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	205.87	19.21	13.11	0.91	0.91	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2126.63	28.84	104.65	2.81	1.28	1.02	1.02	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2098.41	34.81	107.13	2.02	0.90	1.35	1.12	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1889.19	31.33	110.67	2.01	2.87	1.72	1.15	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	450.39	36.51	8.06	0.47	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	504.97	40.03	19.67	0.70	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	510.91	36.26	19.78	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1674.50	37.43	184.55	3.18	0.58	1.59	1.73	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1439.92	32.88	131.33	4.07	0.68	3.05	2.20	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1508.40	31.60	131.06	6.29	0.97	2.26	2.10	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	494.03	28.24	32.28	0.00	0.90	1.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	514.65	35.99	29.00	0.35	0.00	0.00	1.05	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	595.29	32.56	35.20	0.44	0.44	0.44	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1205.89	32.89	89.81	1.69	0.00	0.84	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	977.56	32.00	65.45	1.45	1.04	0.62	2.08	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1047.49	33.08	85.87	1.34	1.34	1.34	1.67	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	427.48	32.36	11.42	2.18	0.27	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	476.99	27.87	14.47	0.54	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	385.54	21.52	23.31	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1995.58	50.25	215.10	3.34	0.19	2.23	2.23	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1340.65	39.42	94.01	2.38	0.87	1.73	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1223.92	41.82	92.89	0.84	1.05	1.26	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	538.47	45.00	16.18	1.01	1.01	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	528.13	44.62	19.93	0.43	1.73	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	571.35	32.69	19.61	0.44	0.87	0.00	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	683.41	57.40	15.34	0.00	0.99	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	646.23	40.62	24.93	0.92	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	644.87	53.04	19.54	0.00	1.40	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	808.08	57.05	19.66	0.28	0.83	0.83	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	928.07	60.37	29.69	0.25	1.23	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	793.10	47.74	26.18	0.00	3.08	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	717.31	55.87	23.28	1.43	0.36	0.72	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	673.11	48.47	11.08	0.00	1.38	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	232.45	21.28	17.02	0.33	0.33	0.00	0.00	1.31
CD8+ T Cells, donor2	11307-117C2	128.77	14.27	12.01	1.50	0.38	0.38	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	158.56	15.40	13.13	0.76	1.01	0.25	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	568.66	33.72	87.86	2.06	1.61	2.75	1.61	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	577.78	27.80	98.49	1.20	0.72	3.59	0.96	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	597.25	29.55	109.16	1.92	1.37	5.75	1.92	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	789.86	37.53	104.47	1.80	0.00	2.40	1.80	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	483.81	28.08	84.23	0.96	0.72	3.12	3.36	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	520.94	26.83	77.31	1.82	1.14	2.27	0.91	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	765.49	31.94	117.55	0.87	0.22	1.96	3.26	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	759.34	32.90	119.23	1.84	1.05	5.53	3.16	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	684.08	29.78	105.30	1.88	0.94	4.69	2.11	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	763.75	30.19	115.02	1.81	0.91	5.43	3.32	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	700.70	28.47	126.66	0.87	2.03	4.94	4.65	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	848.06	39.43	102.31	2.40	0.53	4.53	2.40	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	403.61	15.76	45.09	0.44	0.88	0.88	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	376.64	17.76	46.00	0.46	2.28	0.00	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	256.58	11.19	35.06	1.49	0.75	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	581.29	30.97	85.36	0.00	0.72	0.72	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	601.34	35.10	85.17	1.15	1.44	2.30	1.44	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	527.72	32.76	78.72	0.71	0.94	1.65	2.12	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	864.51	40.25	102.68	3.17	0.95	2.85	3.17	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	798.74	31.37	98.42	2.46	0.62	3.38	2.15	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	754.33	42.64	86.88	1.28	1.92	3.85	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	714.83	40.92	99.82	2.29	0.76	6.12	3.06	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	657.76	33.10	83.16	1.97	0.79	1.18	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	638.41	29.50	103.63	3.03	0.00	2.27	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	247.31	9.64	37.74	0.80	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	246.20	14.69	26.58	0.00	1.40	1.40	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	271.47	19.03	31.05	0.00	3.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	488.01	9.14	32.90	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	616.62	45.46	33.60	3.95	0.00	1.98	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	3412.48	116.91	313.59	2.32	0.53	1.68	1.16	0.74
Chondrocyte - de diff, donor1	11261-116G1	2521.66	61.36	157.04	2.08	2.77	1.73	0.35	2.43
Chondrocyte - de diff, donor2	11338-117F6	2193.03	75.70	175.91	3.91	2.49	1.42	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	1358.18	40.39	154.06	8.76	2.96	2.28	1.59	1.02
Chondrocyte - re diff, donor2	11339-117F7	2692.93	106.54	136.97	0.90	0.90	2.69	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	1671.40	66.73	112.42	6.47	1.21	2.02	2.02	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	1400.51	125.43	56.58	2.41	0.46	0.69	0.69	2.41
Ciliary Epithelial Cells, donor2	11323-117D9	890.33	80.16	42.54	7.48	0.64	1.07	1.50	4.70
Ciliary Epithelial Cells, donor3	11399-118D4	778.60	66.64	41.33	3.19	0.62	0.44	0.62	2.57
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	548.09	63.55	15.50	0.73	9.08	0.37	0.37	0.18
Corneal Epithelial Cells, donor1	11526-119I5	1718.37	148.65	75.75	1.54	1.10	0.66	1.10	2.20
Corneal Epithelial Cells, donor2	11606-120I4	1585.81	117.17	116.04	7.96	0.00	2.28	1.14	5.69
Corneal Epithelial Cells, donor3	11687-122I4	1845.65	144.18	107.62	8.18	1.02	0.77	1.02	4.60
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1014.18	34.34	66.37	1.16	0.50	0.66	0.17	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1039.27	40.06	73.81	0.00	0.95	0.63	0.32	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	1142.18	75.92	48.31	6.90	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	852.04	38.01	69.55	4.21	0.86	0.76	0.54	3.89
Dendritic Cells - plasmacytoid, donor1	11228-116C4	332.76	66.96	7.86	0.68	1.37	0.68	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	359.08	94.67	6.53	0.00	1.31	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	298.59	66.78	4.36	0.48	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	2650.96	132.41	162.43	1.67	0.83	0.33	0.67	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	1268.02	55.16	96.23	1.17	0.00	2.93	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	1717.43	50.06	117.93	2.83	0.57	1.70	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	1263.69	57.80	105.37	2.75	1.18	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	1017.48	34.32	75.34	3.49	2.04	1.16	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	1459.90	67.52	109.87	10.12	1.18	3.29	2.82	0.24
Endothelial Cells - Artery, donor3	11413-118E9	2189.79	92.39	170.40	7.19	1.05	1.05	1.40	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	872.20	40.56	57.19	0.66	0.66	0.89	0.89	1.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	769.80	45.03	48.68	0.30	0.00	1.22	0.30	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	778.90	36.65	50.18	0.56	0.28	0.28	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	1234.29	60.32	83.79	1.78	0.30	0.89	1.49	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	1267.30	49.46	86.43	1.04	3.12	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	358.44	29.35	27.65	2.27	0.00	0.71	0.99	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	1913.37	74.42	116.83	2.80	0.80	2.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	774.66	45.07	60.27	3.14	1.05	2.62	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1624.02	77.41	99.15	3.23	0.50	1.49	1.37	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	634.40	39.11	46.28	3.48	0.43	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	805.19	44.09	53.00	2.44	0.12	0.37	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	1478.76	65.98	105.79	9.10	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2295.27	113.86	159.96	2.10	1.40	3.49	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	1214.29	68.93	97.34	4.87	0.63	0.63	0.47	0.94
Eosinophils, donor1	12244-129H3	747.10	30.49	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	382.86	33.01	8.25	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	260.38	28.53	3.57	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2093.63	130.23	164.19	1.71	0.73	0.98	0.73	2.93
Esophageal Epithelial Cells, donor2	11587-120G3	925.67	52.00	56.16	0.00	2.08	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	1187.62	48.81	178.96	32.54	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1414.63	42.28	153.12	4.93	0.41	2.87	0.82	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	330.76	22.77	32.30	2.63	0.55	6.13	4.60	3.50
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	507.02	36.29	47.45	1.84	1.52	4.55	3.90	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1322.19	87.08	74.59	3.64	0.36	1.21	2.55	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1557.68	104.54	92.94	1.77	1.36	0.55	1.09	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	517.11	40.39	32.91	3.16	0.63	0.84	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1203.10	39.79	56.12	5.27	0.79	0.00	3.43	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	813.56	65.78	45.84	3.99	0.33	1.66	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	1578.17	63.05	119.76	9.53	1.81	1.81	2.72	1.81
Fibroblast - Cardiac, donor2	11345-117G4	2650.54	110.66	187.97	7.58	0.76	2.27	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	935.41	47.31	63.56	5.20	1.58	1.26	2.05	0.47
Fibroblast - Cardiac, donor4	11452-119A3	988.43	62.14	38.80	0.00	0.91	0.91	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	1029.70	58.63	58.50	6.60	0.51	1.02	1.65	2.66
Fibroblast - Cardiac, donor6	11460-119B2	1282.94	56.54	68.67	7.43	0.30	1.21	1.36	3.03
Fibroblast - Choroid Plexus, donor1	11492-119E7	1277.47	67.13	50.92	0.40	1.07	0.80	0.00	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	518.58	37.53	29.77	2.16	0.00	0.43	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	927.21	73.24	51.27	7.32	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	2363.82	193.97	75.42	1.38	0.92	0.69	0.46	3.00
Fibroblast - Conjunctival, donor3	11692-122I9	513.73	52.58	50.54	0.68	0.51	0.34	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	696.13	69.73	39.91	0.94	0.47	1.17	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	2547.54	185.37	130.18	1.42	1.89	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	828.43	72.41	43.88	4.47	1.57	1.09	1.81	1.09
Fibroblast - Dermal, donor4	11450-119A1	1382.77	125.82	54.60	12.32	0.90	1.13	1.92	3.62
Fibroblast - Dermal, donor5	11454-119A5	1500.47	137.29	67.51	9.59	0.35	1.05	1.22	5.23
Fibroblast - Dermal, donor6	11458-119A9	1829.70	152.03	74.23	10.40	0.49	1.30	1.14	5.04
Fibroblast - Gingival, donor1	11237-116D4	927.46	89.75	29.99	1.25	0.62	0.21	0.62	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	771.85	54.50	35.11	3.14	1.57	0.52	0.52	1.05
Fibroblast - Gingival, donor2	11318-117D4	1241.01	112.02	40.59	10.28	0.53	1.45	1.98	0.40
Fibroblast - Gingival, donor3	11394-118C8	545.12	58.30	24.17	0.97	0.48	0.10	0.58	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	498.67	28.05	15.58	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	351.00	23.44	10.92	3.00	0.70	0.35	1.06	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1048.71	96.34	31.49	1.87	0.78	0.62	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	1096.29	77.89	42.33	4.46	0.27	0.95	1.22	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	397.34	51.17	18.00	0.00	0.71	0.00	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	926.31	79.70	36.12	2.92	0.88	1.32	0.88	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	942.61	78.68	34.91	3.41	0.14	1.91	0.82	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	1091.78	72.07	38.72	4.72	0.33	0.99	0.55	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	344.25	29.05	11.59	1.32	0.59	0.59	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	1313.13	137.29	67.97	2.72	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	856.50	95.50	38.80	1.49	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	1045.68	130.42	35.67	6.96	1.69	1.90	1.90	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	3527.01	184.93	117.46	0.00	1.67	0.83	0.83	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	681.13	43.36	43.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	934.78	70.53	50.94	2.52	1.96	0.84	1.12	1.40
Fibroblast - Mammary, donor1	11540-120B1	2098.05	146.15	79.98	0.81	0.41	0.41	0.41	1.62
Fibroblast - Mammary, donor2	11620-122A9	2013.08	195.72	115.83	7.99	0.00	3.99	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	970.87	65.52	35.74	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1619.68	163.13	46.94	2.33	0.00	1.36	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1210.27	114.22	41.71	8.04	0.61	0.61	0.76	3.94
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1268.32	104.34	35.49	0.00	0.00	0.00	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	645.71	45.79	20.23	2.29	0.76	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	556.99	47.52	18.90	4.32	0.54	1.08	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	269.99	29.57	8.35	1.28	0.70	0.12	0.35	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	2041.65	107.55	135.18	5.31	0.33	2.54	1.77	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1644.42	97.73	46.73	0.20	0.41	1.02	0.20	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1545.55	143.66	48.78	5.35	1.34	0.00	0.67	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	785.19	77.89	28.86	1.58	0.40	0.79	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2527.63	68.46	114.70	3.97	0.20	1.98	1.19	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1122.73	48.13	64.12	2.13	0.71	0.18	0.53	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1779.28	75.09	119.83	2.56	1.38	0.79	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1906.22	62.28	95.37	3.91	1.20	0.90	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1612.15	71.46	86.79	4.75	0.86	0.97	0.54	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	2081.28	79.21	91.87	5.31	0.51	1.27	1.52	0.51
Fibroblast - skin normal, donor1	11553-120C5	1111.79	57.10	51.85	1.15	0.82	0.49	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	2411.10	137.55	104.46	1.00	0.60	1.20	0.60	1.20
Fibroblast - skin normal, donor2	11561-120D4	2214.39	83.38	137.03	3.82	0.60	2.11	0.50	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	3854.74	136.61	188.29	6.95	0.00	3.63	3.02	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	1252.13	63.05	61.89	0.91	0.75	0.99	1.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	740.04	37.44	37.44	2.05	0.51	0.68	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1589.28	48.61	101.81	3.61	0.00	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1893.32	102.58	93.95	3.73	0.53	1.60	0.85	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	2400.83	126.17	113.52	2.36	1.69	2.02	2.70	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1135.84	62.41	70.10	4.39	0.47	4.55	2.67	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22071.16	1085.83	664.79	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	527.28	38.35	14.82	3.49	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1435.40	71.60	75.93	0.87	1.39	0.69	1.04	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1711.86	93.43	86.40	2.34	0.78	2.86	1.82	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1474.05	79.46	64.13	0.51	1.53	1.02	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1648.23	137.80	91.87	6.89	1.53	4.59	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1904.01	147.39	96.99	11.49	2.55	7.66	5.10	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2731.12	244.47	94.71	14.26	2.57	3.71	4.28	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	753.09	140.64	27.30	5.79	2.48	1.65	2.21	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	790.01	105.26	40.19	3.65	1.60	3.42	1.60	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1569.79	151.17	56.47	7.33	1.39	3.37	2.18	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	838.21	133.22	27.49	4.23	2.38	2.91	2.91	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	529.34	83.82	24.79	2.94	3.91	2.28	2.61	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	2100.12	207.40	108.79	9.29	1.77	3.98	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	2437.53	203.50	165.63	10.03	1.55	3.11	4.66	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	1296.20	113.29	103.93	7.27	0.74	2.46	1.72	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1672.46	125.45	116.58	5.91	1.61	2.42	2.42	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1566.76	114.97	85.36	4.71	1.12	0.99	1.73	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1704.72	158.77	90.81	10.11	1.66	2.35	2.77	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1568.07	116.70	90.06	9.76	1.22	3.05	2.24	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	1252.02	76.90	81.00	3.19	0.68	1.83	1.37	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	1440.98	112.36	82.09	7.22	1.74	1.62	2.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	1254.85	98.14	76.94	3.72	0.66	1.31	1.09	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	1214.13	72.10	72.98	3.84	0.59	2.07	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	1353.85	108.57	70.10	4.77	1.75	1.11	2.23	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1089.39	80.21	50.49	2.46	1.34	0.89	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	1443.29	78.84	97.59	9.48	1.81	2.02	2.82	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1677.59	114.17	86.52	7.12	1.02	2.04	2.54	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1676.26	97.54	79.27	1.60	1.86	1.15	0.53	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1750.64	103.33	122.58	0.52	1.14	0.62	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1926.53	105.54	144.99	0.85	1.02	1.02	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1596.84	100.69	110.43	4.20	1.44	1.66	1.88	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2019.67	110.57	129.20	1.41	1.16	1.41	2.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2106.74	96.78	136.80	1.02	0.82	1.84	1.43	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1580.09	85.62	124.20	8.05	0.83	0.83	2.68	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1904.88	106.53	144.92	4.73	0.35	1.73	1.84	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	1509.55	71.38	117.57	4.50	1.50	2.33	1.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1216.34	67.23	106.03	1.76	1.32	1.10	1.98	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1222.17	89.17	87.94	5.66	0.74	1.60	2.09	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	1540.21	82.34	106.01	4.86	0.97	3.24	1.30	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	842.52	57.41	69.27	4.49	0.32	2.89	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1895.09	101.77	172.93	6.63	0.47	2.75	2.94	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	1842.91	78.61	188.39	3.80	0.32	3.01	1.11	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1755.19	84.54	144.14	7.30	0.91	4.56	1.82	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1835.59	93.98	141.44	6.38	0.84	1.88	1.88	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1718.24	76.19	166.42	4.61	0.66	1.10	1.32	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	1251.53	63.12	94.54	3.93	1.12	0.84	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	764.03	64.16	31.39	1.94	0.83	0.65	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	1035.92	72.47	44.66	3.74	1.34	1.60	1.60	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	856.52	60.59	41.31	2.75	0.92	0.61	1.38	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	861.42	67.62	35.75	3.11	1.81	1.04	1.17	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	639.73	51.77	33.61	1.63	1.36	1.08	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	688.00	38.53	32.63	2.21	0.55	0.92	0.55	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	697.41	44.30	46.49	3.29	0.88	1.97	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	391.74	24.79	18.84	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	655.08	40.37	29.55	1.71	1.06	0.79	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	666.81	39.75	27.24	1.61	0.61	0.81	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	492.82	38.38	37.62	0.00	1.27	0.00	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2483.27	234.49	80.42	4.58	1.59	2.39	1.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1282.07	168.56	51.00	6.47	0.46	1.69	2.47	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1969.93	207.45	60.76	5.73	1.84	1.23	1.64	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3002.25	232.82	108.27	2.50	2.82	3.44	1.88	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3027.58	257.69	121.22	1.98	2.54	4.52	3.39	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1534.43	146.20	51.65	5.53	1.38	2.31	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1336.39	126.21	84.14	9.90	2.47	7.42	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1793.25	131.13	92.83	10.83	2.32	5.42	4.25	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1716.78	107.50	109.10	4.81	0.00	4.81	3.21	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1391.06	125.20	50.43	8.69	1.74	5.22	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1566.21	101.55	77.46	5.86	1.95	5.21	1.95	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1568.96	108.30	78.24	10.71	1.24	0.82	3.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1229.61	109.96	79.97	10.00	0.00	3.33	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1520.16	88.37	64.60	5.59	3.08	3.92	1.68	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1504.79	97.73	65.70	2.61	2.29	1.31	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1265.80	114.08	54.52	5.87	0.00	2.52	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1575.41	106.87	68.07	5.73	1.27	2.23	2.86	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1640.91	103.94	74.73	8.49	2.72	3.06	2.38	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1495.11	137.82	60.56	0.00	0.00	6.26	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1998.72	115.69	111.10	8.59	1.72	7.45	3.44	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1698.65	115.14	76.07	5.92	0.89	3.55	2.66	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1622.99	71.15	93.18	6.78	0.00	6.78	6.78	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1853.99	101.90	92.37	13.25	1.24	5.38	4.56	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	2008.80	112.76	112.99	7.13	1.15	2.99	2.99	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1575.28	105.37	79.03	5.27	0.00	10.54	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1366.20	72.27	76.11	7.30	1.54	4.23	2.31	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1547.38	79.86	85.08	5.22	1.30	2.93	2.28	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1404.56	82.27	100.33	5.35	0.00	5.35	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1216.68	87.07	68.58	6.55	1.93	3.47	1.54	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1384.42	87.98	77.71	4.45	2.40	1.71	1.71	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	675.86	57.15	24.85	2.48	0.00	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1263.61	105.69	75.97	2.83	0.00	2.83	2.36	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	969.21	71.21	50.09	4.22	1.81	3.02	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1040.75	75.79	49.34	8.14	2.03	1.02	3.05	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1219.25	81.36	68.60	7.18	0.80	4.39	2.79	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1201.32	76.47	68.08	5.92	1.97	1.48	2.96	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	932.55	86.17	47.22	10.62	2.36	4.72	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1058.37	78.77	64.18	4.08	1.75	2.92	1.17	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	764.53	67.15	45.64	2.63	0.00	2.19	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	822.26	72.05	46.62	7.63	0.85	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1504.22	68.05	95.51	6.57	1.79	3.58	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	2011.35	94.62	163.53	7.76	2.43	8.73	1.94	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1432.34	58.21	73.04	5.71	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	879.04	44.91	54.89	4.16	1.66	0.42	2.08	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2760.53	200.15	154.05	6.75	1.12	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	381.54	22.52	31.72	2.85	0.00	1.27	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	564.79	32.58	48.46	2.92	1.25	0.84	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	2975.32	102.35	235.91	13.69	5.92	5.45	3.25	2.32
Hep-2 cells mock treated, biol_rep2	11899-125E9	2758.72	91.83	219.10	15.53	4.90	2.70	2.70	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	2623.57	105.79	222.95	10.92	2.96	2.73	0.91	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2921.39	106.58	233.70	18.36	4.26	4.59	3.61	3.06
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2823.52	92.84	240.92	9.46	3.01	5.16	2.15	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2556.04	83.96	213.99	7.53	4.31	2.80	0.86	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2891.51	90.79	247.21	8.47	2.74	4.23	2.62	3.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2731.07	76.85	224.56	9.26	4.29	3.95	0.69	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2561.38	88.42	205.04	15.70	6.41	2.88	0.96	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	829.92	38.05	59.32	3.36	0.56	0.00	0.00	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1760.17	99.54	134.17	4.76	0.43	0.00	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	1195.00	42.30	116.33	7.93	0.00	2.64	7.93	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1488.48	118.51	55.02	1.41	2.12	0.71	1.76	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	824.59	66.11	37.78	2.91	0.73	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1423.19	79.38	74.31	7.87	0.17	1.40	1.57	1.40
Hepatocyte, donor1	11523-119I2	456.40	13.32	7.26	3.63	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	643.17	22.62	12.93	2.15	4.31	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	386.53	20.25	9.20	1.23	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1050.83	92.68	60.05	4.57	0.65	1.31	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	654.91	32.86	12.06	1.75	1.57	0.52	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	2099.67	121.70	167.53	2.74	0.27	2.33	1.10	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	2457.96	168.75	175.11	9.55	0.00	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	2870.38	193.58	213.61	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1814.58	189.58	189.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1979.66	148.13	131.52	9.69	1.38	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	3075.77	190.20	205.22	15.02	5.01	5.01	2.50	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	3014.54	249.23	201.76	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	1947.81	115.33	125.58	5.13	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	3153.83	182.83	196.54	13.71	0.00	0.00	9.14	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	2051.53	196.54	113.70	6.50	1.62	3.25	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	2322.56	171.73	163.40	6.67	5.00	1.67	5.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	2436.11	152.48	217.83	7.26	0.00	10.89	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2329.31	222.34	131.02	14.56	7.94	3.97	6.62	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2332.59	185.14	149.67	5.54	4.43	1.11	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	3027.73	235.72	272.39	5.24	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2004.86	210.37	114.01	11.97	3.15	2.52	3.78	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	2360.15	221.17	126.82	4.64	4.64	4.64	0.00	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	2312.29	131.71	204.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2029.85	215.78	119.52	13.57	4.52	5.81	1.94	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	2241.02	170.65	136.84	1.61	0.00	8.05	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	2533.02	131.43	215.07	0.00	0.00	11.95	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2229.51	184.16	124.68	10.59	3.26	2.44	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3400.46	313.60	205.71	5.04	2.52	2.52	3.78	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	2357.08	86.23	86.23	14.37	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	2147.45	197.71	110.91	12.06	4.82	1.61	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2139.24	174.50	144.96	12.00	1.85	0.92	2.77	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	1176.30	165.89	105.57	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1823.48	202.50	101.02	11.80	3.78	3.30	3.30	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2185.83	163.26	124.26	12.70	0.91	3.63	3.63	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	2226.11	117.94	103.20	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1952.08	178.64	103.31	7.53	3.23	0.00	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2628.59	228.68	143.56	7.62	1.27	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2349.54	164.30	246.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2098.60	190.67	121.80	13.39	2.55	1.28	3.83	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	2198.13	180.44	174.98	3.65	1.82	1.82	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1738.48	110.63	268.67	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2235.02	206.36	116.39	12.14	2.14	3.57	2.14	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	2223.27	199.10	109.50	19.91	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	1918.07	145.94	104.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1911.22	202.17	105.25	8.95	2.16	2.47	1.85	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1984.31	143.99	131.70	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	2285.05	150.87	172.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1991.59	194.71	118.22	8.34	3.48	2.09	0.70	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2230.80	232.37	130.57	6.64	0.00	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	2110.55	204.25	126.44	6.48	0.00	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1738.63	218.85	89.81	10.46	1.74	1.74	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2132.80	218.23	137.24	9.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	1599.42	195.14	104.54	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1782.58	194.15	106.68	12.80	0.00	2.13	2.13	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1844.02	145.47	87.28	5.54	1.39	1.39	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	1746.81	122.53	94.04	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1821.52	205.25	84.68	9.20	3.68	4.60	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	1615.52	154.29	111.94	9.08	0.00	3.03	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	1508.71	149.01	111.76	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1391.50	155.43	81.42	4.23	2.11	2.11	3.17	2.11
Keratinocyte - epidermal, donor1	11272-116H3	1461.20	82.33	108.36	1.22	0.90	0.65	1.31	0.33
Keratinocyte - epidermal, donor2	11349-117G8	2286.90	187.99	111.27	4.10	1.17	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	1086.08	89.54	42.78	4.64	1.61	1.14	0.66	0.85
Keratinocyte - oral, donor1	11251-116E9	1657.70	151.77	79.69	4.20	0.79	1.14	0.79	0.45
Keratocytes, donor1	11527-119I6	2953.85	208.71	73.24	1.72	1.72	1.38	0.34	4.13
Keratocytes, donor2	11607-120I5	2492.42	137.10	154.68	4.69	1.17	1.17	0.00	2.34
Keratocytes, donor3	11688-122I5	744.94	46.44	19.17	3.36	0.79	0.40	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	87.92	19.78	2.20	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	1292.34	86.30	124.06	7.55	0.00	2.16	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	1427.81	111.41	72.89	0.81	0.35	0.23	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	937.25	69.02	43.39	0.81	0.40	0.20	0.81	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	969.84	62.61	63.91	2.13	0.36	1.66	1.07	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	606.43	43.54	38.51	1.95	0.28	1.40	0.56	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	592.97	43.13	42.97	2.52	0.79	0.79	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	602.24	38.18	45.71	3.76	1.08	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	639.47	39.08	44.75	0.63	1.26	1.89	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	602.79	40.65	45.07	3.88	0.22	0.22	0.54	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	483.03	34.06	41.45	0.82	0.00	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	645.45	44.24	47.53	1.01	0.25	1.52	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	583.27	40.11	40.25	1.83	0.70	0.42	0.70	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	563.63	26.90	44.70	1.58	0.00	2.77	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	567.50	30.63	42.65	1.94	0.58	0.97	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	654.31	49.99	49.99	1.85	1.67	0.74	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	544.24	32.06	34.15	1.05	0.70	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	571.26	37.21	46.99	0.72	0.24	0.24	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	583.04	40.65	43.40	1.24	1.10	0.55	1.24	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	518.29	35.11	47.43	1.85	0.31	1.23	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	675.24	44.27	55.18	1.25	0.62	0.31	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	706.89	50.69	52.70	1.46	0.18	0.55	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	534.15	32.91	44.43	1.65	0.00	0.33	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	708.46	36.32	51.84	0.29	0.00	1.46	0.59	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	772.18	52.77	69.45	3.24	0.75	1.00	0.75	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	599.90	27.16	51.41	2.42	0.00	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	567.68	36.09	46.05	1.08	0.81	0.54	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	645.17	34.21	47.99	3.33	0.15	0.76	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	676.01	34.22	62.21	0.52	0.52	2.07	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	523.27	28.48	39.37	0.63	0.42	1.47	0.63	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	567.50	41.05	45.56	1.20	0.60	1.35	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	671.37	26.14	49.53	0.69	0.69	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	567.83	37.82	43.27	1.13	0.94	1.69	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	619.00	38.81	40.82	2.97	0.64	0.85	0.53	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	538.37	31.50	46.03	0.97	0.48	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	570.94	31.42	45.98	1.32	0.33	1.32	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	626.15	42.12	46.46	3.22	0.62	0.25	0.74	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	622.69	34.43	54.05	1.48	0.37	0.00	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	576.69	36.32	41.26	1.73	0.00	0.49	0.25	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	554.65	39.32	43.72	1.51	0.00	0.69	0.69	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	521.05	23.80	41.17	2.57	0.32	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	616.27	37.43	47.48	0.91	1.22	0.91	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	556.65	33.45	41.43	1.68	0.70	0.70	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	545.08	33.78	41.25	2.49	0.71	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	744.13	37.81	67.87	1.45	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	738.05	45.75	53.68	2.65	1.24	0.78	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	625.25	35.09	44.05	2.15	1.07	1.07	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	568.74	34.63	43.45	1.96	0.00	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	884.25	59.80	55.56	3.77	0.71	0.71	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	986.55	60.27	59.90	0.99	1.24	0.87	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	598.57	31.50	54.30	1.02	1.02	0.51	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	557.33	39.38	30.43	2.39	0.60	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	1985.02	106.50	179.01	2.27	9.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1301.82	42.96	165.70	2.30	9.97	2.30	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1306.32	54.92	131.37	6.68	2.97	1.48	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1456.83	45.27	189.98	5.50	3.81	4.23	3.81	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1223.78	50.64	138.55	16.18	4.92	2.11	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1247.78	32.69	160.64	5.60	5.60	2.80	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1445.84	56.68	201.99	23.19	4.64	2.06	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1372.64	45.20	181.99	11.89	4.76	1.19	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1851.16	78.26	193.85	4.52	4.30	1.58	2.49	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1450.65	44.50	178.86	11.05	1.45	2.91	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1308.21	37.36	159.81	8.55	0.45	1.35	2.70	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2007.90	75.06	215.69	2.85	4.88	2.03	2.03	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1533.38	50.84	189.49	14.38	4.11	2.05	2.57	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1308.03	40.23	144.67	5.29	1.41	3.53	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1215.34	27.98	142.59	6.66	3.33	2.67	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1354.46	38.71	167.08	10.70	5.60	2.55	2.04	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1320.15	46.96	148.61	7.74	2.93	3.20	1.33	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1449.59	57.44	161.36	13.42	3.78	2.08	1.89	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1481.14	43.56	223.95	12.27	4.91	0.61	3.68	5.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1493.85	37.51	156.56	8.15	4.08	3.26	4.08	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1372.95	43.52	165.35	12.91	2.08	2.92	2.50	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1601.13	50.73	177.69	17.66	3.08	3.08	0.84	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1327.08	46.37	142.19	10.30	4.12	4.12	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1411.75	45.29	157.64	17.13	2.61	3.77	3.77	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1360.43	49.32	163.51	9.27	2.39	2.09	1.20	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1236.53	42.60	116.74	12.17	1.66	2.77	2.21	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1442.58	50.55	177.45	12.73	4.24	3.89	3.89	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1395.83	44.99	176.65	8.85	2.58	2.58	1.84	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1454.06	55.26	224.50	13.82	2.30	3.45	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1561.49	58.33	192.64	11.51	1.92	4.61	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1610.64	54.35	232.11	27.74	4.53	4.53	3.40	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1466.18	36.10	169.84	6.56	5.74	1.64	4.10	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1472.24	54.68	169.91	14.91	4.07	3.62	3.62	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1638.09	51.71	203.23	14.36	4.31	1.44	1.44	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1437.79	53.78	165.07	5.23	1.49	0.75	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1558.46	57.97	194.34	23.41	3.34	4.83	2.97	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1647.18	49.97	195.56	7.75	2.15	1.72	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1697.18	51.38	219.21	9.42	5.14	1.71	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1727.19	55.97	222.56	17.33	5.00	3.33	3.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1732.10	54.90	188.84	10.26	4.83	2.41	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1395.69	59.72	150.02	7.82	2.84	2.13	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1526.11	51.90	178.39	17.19	3.44	3.78	2.75	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1685.39	57.97	213.09	11.81	4.83	1.61	3.22	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1434.93	43.77	183.15	12.12	3.37	0.67	2.02	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1503.49	54.45	198.91	18.52	4.82	3.70	3.70	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2266.55	103.50	166.30	2.33	4.65	1.16	0.00	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1283.04	44.43	137.51	0.00	4.23	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1457.35	62.02	191.67	10.40	2.40	3.60	3.20	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1418.86	50.15	163.55	5.09	4.36	0.73	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1513.87	58.26	151.77	7.67	7.67	1.53	3.07	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1574.54	50.81	190.41	20.22	5.92	4.93	5.43	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1343.65	38.58	155.25	4.70	2.82	2.82	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1372.20	61.34	155.87	4.53	9.05	2.01	1.51	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1426.22	34.25	178.90	10.36	4.51	1.35	3.60	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1557.60	27.54	184.16	10.33	3.44	5.16	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1544.45	56.11	181.25	12.91	4.45	2.23	1.78	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1400.65	50.44	172.83	10.95	3.91	2.74	4.30	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1476.49	58.72	191.98	8.58	4.62	4.62	3.30	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1464.41	52.41	131.81	5.19	4.67	2.08	3.63	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1601.93	56.88	181.59	17.07	3.06	2.63	3.06	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1360.85	39.70	177.24	6.71	6.15	1.12	4.47	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1257.80	50.79	147.51	5.30	3.09	2.65	1.32	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1415.57	54.77	165.47	15.81	4.24	4.24	3.47	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1470.45	52.66	192.92	10.13	3.54	4.56	1.01	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1366.40	43.26	143.22	6.25	3.36	1.92	0.96	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1431.96	53.27	153.85	11.93	4.77	2.39	3.18	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1471.66	44.36	198.69	6.08	4.25	2.43	3.04	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1296.94	43.58	173.62	8.99	2.77	1.38	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1445.11	50.92	174.42	11.78	4.18	1.52	2.66	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1562.68	44.93	203.98	14.46	5.16	3.61	2.07	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	1119.82	31.44	168.70	6.65	1.21	0.60	2.42	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1349.36	51.97	170.49	14.58	5.39	1.58	3.80	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1406.82	41.05	190.31	5.86	2.67	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1395.30	31.61	220.10	4.60	1.72	2.87	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1528.82	47.82	195.41	18.00	5.66	4.11	3.60	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1662.28	44.56	227.06	14.15	0.71	2.83	2.12	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	1504.97	38.59	229.26	15.32	3.40	1.70	2.27	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1465.24	47.01	192.62	10.40	4.99	2.08	1.66	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	1758.71	54.81	240.39	15.66	3.13	8.61	3.92	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1466.84	43.42	192.91	6.68	0.00	2.51	2.09	3.76
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1546.78	58.08	167.27	16.73	2.79	4.65	4.65	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1727.48	52.19	232.83	10.70	3.35	1.34	4.01	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	1546.72	42.77	210.11	5.35	3.74	2.14	2.14	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1803.08	61.42	221.85	16.57	3.64	5.66	3.64	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1629.94	59.65	198.24	5.51	4.59	8.26	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	1580.84	41.79	240.95	11.56	0.00	1.78	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1719.87	58.70	223.96	9.69	3.42	1.14	1.71	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1780.74	53.68	213.20	9.97	3.83	3.83	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	1592.83	29.55	211.76	4.92	1.64	0.55	2.74	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1608.96	59.69	204.01	12.47	4.01	5.35	1.34	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2405.36	94.10	254.24	3.64	3.38	2.34	1.82	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	1745.30	45.75	246.68	9.28	2.65	3.98	1.99	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1937.26	97.69	295.16	8.31	8.31	10.39	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	1183.11	80.00	39.43	1.14	1.14	0.00	0.23	4.79
Macrophage - monocyte derived, donor2	11313-117C8	1259.78	76.71	58.91	0.92	0.73	0.55	1.47	1.28
Macrophage - monocyte derived, donor3	11389-118C3	745.33	59.25	36.83	4.06	0.26	0.39	0.52	1.84
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1698.21	95.58	75.94	0.53	1.06	0.53	0.00	2.12
Mallassez-derived cells, donor2	11929-125I3	1263.97	77.96	59.42	1.11	1.11	0.48	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	1957.50	102.29	115.64	1.67	2.08	0.42	0.56	0.14
Mammary Epithelial Cell, donor1	11273-116H4	1956.70	123.16	160.03	2.09	1.20	0.60	0.80	0.50
Mammary Epithelial Cell, donor2	11350-117G9	1894.52	100.76	146.80	2.03	0.58	0.29	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	2034.57	155.39	125.46	6.24	1.50	1.50	1.25	0.25
Mast cell - stimulated, donor1	11487-119E2	368.12	29.15	35.25	0.00	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	413.10	54.39	15.79	0.22	0.32	0.32	0.54	0.11
Mast cell, donor2	11565-120D8	205.94	61.22	4.16	0.59	0.30	0.30	0.89	0.00
Mast cell, donor3	11566-120D9	188.20	62.81	2.70	0.45	0.68	0.00	0.68	0.23
Mast cell, donor4	11567-120E1	158.67	54.25	2.48	0.18	1.60	0.00	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	986.84	83.28	84.61	1.22	1.11	1.22	0.78	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	703.92	54.28	108.56	1.17	0.58	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	509.94	77.21	17.21	1.61	0.46	1.15	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	409.38	53.56	27.95	0.67	1.00	0.50	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	848.22	56.71	48.26	0.50	0.40	0.90	0.50	0.40
Melanocyte - dark, donor2	11582-120F7	669.32	45.68	37.72	1.38	1.04	0.69	0.69	1.04
Melanocyte - dark, donor3	11663-122F7	903.19	84.83	29.77	1.01	0.51	0.22	0.36	0.07
Melanocyte - light, donor1	11274-116H5	685.24	63.00	19.28	1.18	1.65	0.71	1.41	0.00
Melanocyte - light, donor2	11351-117H1	842.16	92.82	20.47	2.73	0.00	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	603.59	52.90	34.69	0.87	0.00	0.87	2.60	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	1096.65	79.03	23.95	5.73	0.62	1.77	2.60	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	549.72	42.49	24.20	1.34	0.00	0.54	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	315.53	29.20	6.70	1.07	0.27	0.54	0.27	0.27
Meningeal Cells, donor1	11493-119E8	2686.39	189.56	85.35	0.74	0.25	0.37	0.25	1.61
Meningeal Cells, donor2	11573-120E7	927.83	67.34	34.33	1.76	0.88	0.00	1.32	0.44
Meningeal Cells, donor3	11654-122E7	2113.50	144.01	110.60	1.63	0.16	1.14	1.39	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1851.52	175.66	88.68	2.57	1.14	0.57	0.29	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	700.90	30.49	47.50	0.40	0.60	0.30	0.50	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	574.29	42.05	42.05	0.00	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1704.53	168.75	75.87	1.31	0.00	1.31	1.31	6.54
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1118.75	113.38	43.06	2.15	1.44	2.15	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	437.51	31.77	14.61	1.06	0.21	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	486.56	41.22	16.08	2.51	0.00	1.51	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2490.90	179.76	122.84	1.32	0.88	0.88	0.44	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2155.96	148.31	124.93	7.31	1.46	2.92	0.00	5.11
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1898.10	139.95	109.46	6.75	0.82	1.84	0.82	2.66
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	1654.19	83.24	261.50	1.25	0.14	2.08	0.42	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	910.35	57.25	26.02	0.00	1.12	0.00	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1855.59	86.97	131.05	2.11	0.26	0.92	1.84	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	433.24	32.64	20.18	0.00	1.19	0.00	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	422.73	35.03	25.69	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1803.37	128.72	106.31	6.40	0.00	0.64	0.64	5.12
Mesenchymal stem cells - adipose, donor0	11217-116B2	1708.78	182.89	87.90	1.42	0.71	0.71	1.06	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	1856.33	80.06	122.28	2.81	0.00	1.88	0.94	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	1375.19	111.03	73.29	7.26	1.45	2.18	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	579.41	51.97	30.50	0.27	1.06	0.53	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	588.05	53.55	23.52	0.00	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	437.63	28.33	22.47	2.53	0.72	0.51	0.79	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	347.03	21.61	14.85	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	723.31	38.17	32.51	4.43	0.49	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	522.96	40.64	30.03	1.18	0.29	0.29	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	138.28	10.37	13.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	691.80	37.81	26.97	2.17	0.31	0.93	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	510.70	37.34	25.31	0.41	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	108.85	9.26	6.95	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	638.42	41.04	30.03	1.50	1.00	0.50	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	416.60	37.24	20.48	1.40	0.47	0.00	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	537.10	27.84	24.79	2.64	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	472.38	37.22	28.11	0.40	0.00	1.58	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	814.14	41.59	46.02	2.65	0.00	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	691.11	50.53	41.41	1.90	0.76	0.76	0.38	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	127.64	5.26	9.21	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	615.24	33.32	28.86	2.55	0.64	1.06	0.85	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	199.82	19.34	11.97	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	407.14	27.42	18.48	1.19	0.60	0.30	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	93.89	8.38	8.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	574.57	29.10	29.10	2.76	0.75	1.51	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	387.16	27.57	21.15	0.95	0.95	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	271.47	8.85	16.03	0.00	0.55	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	623.28	26.94	31.77	1.84	0.23	0.00	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	426.99	38.49	24.82	0.42	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	535.66	21.20	25.07	2.04	0.20	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	614.01	28.10	27.25	1.72	0.86	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	310.98	23.79	18.67	1.11	0.00	0.22	0.67	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	444.82	20.15	23.87	1.75	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	193.15	22.31	9.13	0.51	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	159.07	8.28	18.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	383.23	16.31	20.93	1.63	0.27	0.27	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	360.55	28.82	23.23	1.47	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	151.56	3.27	11.99	0.00	0.00	0.00	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	794.84	37.48	32.68	4.32	0.48	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	446.26	31.62	23.61	0.40	0.80	0.40	1.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	212.54	17.83	6.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	886.02	31.04	40.55	2.50	1.50	1.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	485.05	53.89	0.00	0.00	0.00	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	142.70	4.08	10.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	898.62	33.72	70.07	3.94	1.31	2.19	1.75	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	108.16	12.14	12.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	272.17	13.45	21.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1140.68	43.63	70.41	2.73	0.50	1.24	0.74	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	177.45	15.31	11.83	1.39	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	240.88	19.89	28.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1528.19	59.83	91.28	4.10	0.34	2.39	2.05	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	226.25	14.00	14.88	0.88	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	387.76	24.50	29.12	0.71	0.71	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1467.28	57.23	95.39	5.89	0.56	2.24	1.12	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	357.44	25.77	20.78	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	310.02	21.56	20.98	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	947.23	43.14	52.49	0.60	0.00	1.81	0.30	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	554.30	42.16	26.30	0.83	0.83	0.83	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	202.13	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	919.86	35.10	57.26	9.24	0.92	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	490.01	27.89	27.89	1.71	0.57	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	770.36	45.05	47.26	2.21	0.55	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1157.88	56.75	67.38	5.18	0.52	0.52	1.81	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	403.24	35.18	15.87	1.29	1.29	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	293.46	17.79	10.80	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	654.95	29.62	33.09	2.14	0.80	0.80	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	492.10	36.22	24.25	0.30	0.60	0.60	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	642.71	42.38	34.61	1.98	0.28	0.00	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1230.42	60.20	71.03	5.73	0.96	1.91	1.59	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	547.30	38.70	19.68	0.22	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	527.09	36.02	36.02	0.38	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1138.41	54.26	59.95	2.56	1.42	0.85	0.85	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	698.08	43.26	37.61	1.23	0.74	0.98	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	280.22	26.72	13.69	0.00	0.65	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	828.57	41.16	40.28	4.41	0.29	3.23	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	536.00	38.64	22.78	2.31	0.58	0.58	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1004.81	68.00	45.75	0.41	0.82	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	659.59	41.99	30.08	1.19	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1024.59	71.57	11.30	3.77	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	682.60	44.56	21.39	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	973.56	41.07	22.01	4.27	0.33	0.66	1.31	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1096.13	59.96	42.08	6.31	0.00	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	678.86	52.39	21.94	0.20	0.20	0.99	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	516.88	34.46	16.76	1.86	0.93	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	658.68	40.93	18.03	2.25	0.00	0.38	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	756.68	34.89	45.54	2.13	0.00	1.86	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	850.75	54.97	18.44	0.90	0.68	0.34	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	709.47	34.63	16.21	1.47	0.74	0.74	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	772.42	42.14	16.49	1.83	0.37	1.10	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	812.02	46.67	32.67	4.67	1.56	3.11	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	536.58	33.67	18.17	1.60	1.07	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	699.37	15.46	23.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	941.26	51.51	24.24	8.08	0.00	0.00	2.02	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	437.66	25.72	16.87	2.95	0.00	0.84	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	168.88	2.72	1.36	0.00	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	341.42	19.07	8.90	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	340.13	26.72	4.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	116.30	7.55	3.02	0.00	3.02	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	194.15	0.00	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	264.26	0.00	16.31	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	513.27	23.76	52.28	0.00	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1402.92	68.29	81.22	1.29	1.29	1.94	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	763.01	47.04	47.56	0.52	0.52	0.00	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	259.65	22.69	21.36	1.33	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	158.60	13.77	10.02	0.00	0.83	1.25	0.83	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	874.46	65.03	37.84	4.56	0.76	1.33	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	526.63	47.88	30.32	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	150.27	12.24	8.84	0.68	0.00	2.04	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1817.43	154.36	53.29	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	176.62	14.65	12.14	0.42	0.00	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	357.26	42.54	14.64	0.23	0.46	0.23	0.70	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	167.54	20.81	8.11	0.27	1.08	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	370.65	29.01	19.97	1.05	0.63	0.63	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2583.26	322.91	77.94	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	262.57	26.80	21.34	0.99	0.99	0.00	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	229.80	17.32	11.37	1.35	1.08	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	199.93	21.08	12.69	0.23	0.68	1.59	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	135.21	21.72	6.53	0.65	0.49	0.16	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	384.38	28.80	18.23	2.92	0.91	0.73	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	145.34	16.44	14.32	1.06	1.06	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	120.06	12.61	4.80	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	368.87	27.57	15.42	1.31	0.66	0.98	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	110.91	16.26	6.50	0.00	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	232.12	15.52	13.41	1.06	0.53	0.00	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	144.87	14.77	7.74	0.70	0.70	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	118.60	8.73	6.44	0.00	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	133.36	18.00	6.11	0.00	0.64	0.64	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	396.62	31.04	15.18	2.76	0.00	0.69	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	816.69	60.68	17.70	0.00	5.06	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	199.84	15.37	7.80	0.89	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	108.39	8.89	4.23	0.42	0.00	1.27	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	150.96	12.82	7.12	1.42	0.47	0.47	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	203.03	16.74	7.30	0.43	0.00	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1588.89	108.33	36.11	9.03	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	151.95	11.66	6.66	1.33	1.33	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	156.00	10.37	8.57	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	153.16	8.73	8.33	0.40	0.00	1.59	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	199.66	21.36	5.57	0.00	0.93	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	223.62	17.03	9.46	1.51	0.00	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	134.92	12.38	8.15	0.00	0.00	0.98	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.65	6.10	3.49	0.00	0.00	0.87	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	192.67	10.40	12.21	0.90	0.90	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	150.81	10.58	10.58	1.76	0.88	1.76	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	170.20	16.62	5.32	1.99	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	123.51	11.91	5.95	0.50	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	107.57	6.51	6.13	0.38	1.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	320.29	28.73	9.68	0.91	0.91	1.21	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	334.19	15.91	19.23	1.33	0.44	0.22	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	124.69	9.49	6.78	0.00	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	843.07	51.10	30.66	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	135.35	14.02	6.71	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	101.66	6.92	3.78	0.00	0.00	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	72.03	11.80	4.84	0.30	1.21	0.91	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	104.43	12.66	7.91	1.58	1.58	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	309.48	14.74	12.47	1.13	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1163.31	45.52	20.23	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1645.65	76.15	145.60	5.71	0.87	1.49	2.11	5.22
Myoblast, donor2	11322-117D8	1163.96	70.00	93.21	12.27	2.11	1.92	2.88	4.99
Myoblast, donor3	11398-118D3	1685.16	129.49	105.77	1.51	2.19	0.84	0.34	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	2547.70	48.01	181.69	5.11	1.17	1.90	1.17	1.31
Natural Killer Cells, donor1	11230-116C6	284.76	25.83	14.15	0.92	1.23	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	140.83	16.89	9.95	3.02	0.90	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	168.23	19.88	8.65	0.37	0.55	0.18	0.37	0.55
Neural stem cells, donor1	11275-116H6	782.86	68.60	21.41	0.00	1.09	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	535.33	42.36	21.18	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	795.39	62.58	25.03	4.55	1.14	0.00	4.55	0.00
Neurons, donor2	11574-120E8	783.12	79.26	20.92	1.98	0.22	0.66	0.88	0.22
Neurons, donor3	11655-122E8	692.26	69.88	24.66	5.76	0.82	1.64	1.64	0.00
Neutrophils, donor1	11233-116C9	109.50	4.64	0.93	0.93	0.00	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	127.55	0.00	2.90	5.80	0.00	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	247.39	18.33	3.67	1.22	1.22	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	913.19	68.99	49.28	1.42	0.83	0.36	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	463.98	40.70	40.70	0.33	1.95	0.65	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	1206.52	65.18	83.83	2.61	0.20	0.60	0.40	1.20
Olfactory epithelial cells, donor1	11933-125I7	843.12	50.11	56.57	3.58	0.14	2.75	0.14	0.69
Olfactory epithelial cells, donor2	11934-125I8	957.06	60.94	54.86	17.08	1.16	2.46	2.89	1.74
Olfactory epithelial cells, donor3	11935-125I9	607.71	43.13	26.79	2.38	1.02	1.14	0.91	0.45
Olfactory epithelial cells, donor4	11936-126A1	805.87	43.73	41.20	1.95	0.88	0.58	0.29	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	1928.83	125.18	102.31	1.20	0.00	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	2182.24	78.06	284.58	1.70	1.49	1.06	1.06	0.21
Osteoblast - differentiated, donor2	11353-117H3	328.07	22.86	34.29	0.00	1.14	2.29	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	456.84	25.45	30.41	4.97	1.86	1.24	0.00	0.62
Osteoblast, donor1	11277-116H8	3201.45	254.46	148.73	3.52	1.56	1.76	0.98	0.78
Osteoblast, donor2	11354-117H4	1897.66	110.26	95.52	4.92	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	2421.04	127.97	191.06	8.00	1.07	3.02	1.07	1.96
Pancreatic stromal cells, donor1	11249-116E7	846.23	82.80	28.22	2.53	0.59	1.43	1.01	0.25
Pericytes, donor1	11491-119E6	1060.59	95.91	39.17	0.45	0.33	0.78	0.22	1.67
Pericytes, donor2	11571-120E5	439.60	56.14	26.03	1.36	1.36	0.23	0.00	1.58
Pericytes, donor3	11652-122E5	3456.00	131.43	437.21	13.63	0.41	3.87	3.87	9.56
Perineurial Cells, donor1	11499-119F5	2457.99	154.84	179.59	1.81	0.68	1.47	1.47	0.90
Perineurial Cells, donor2	11579-120F4	924.71	76.65	46.47	1.10	0.64	0.46	0.28	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	467.91	37.61	16.57	0.96	0.32	0.00	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	328.36	30.36	11.51	4.90	0.49	0.49	0.98	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	231.65	17.99	9.19	2.07	0.78	0.00	0.26	0.39
Placental Epithelial Cells, donor1	11278-116H9	1269.97	121.26	27.03	1.20	4.30	1.91	0.48	0.48
Placental Epithelial Cells, donor2	11355-117H5	727.43	82.06	17.74	1.11	4.44	1.11	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	644.74	68.13	19.63	2.75	2.94	0.79	1.18	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	463.29	22.47	34.18	4.11	1.27	6.96	8.23	1.27
Preadipocyte - breast, donor1	11467-119B9	1010.16	44.08	60.40	0.94	1.13	0.56	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2162.19	104.81	90.72	1.57	0.65	0.91	1.70	0.26
Preadipocyte - breast, donor2	11328-117E5	777.89	41.88	38.73	7.88	0.68	2.93	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	1107.46	53.60	90.89	1.07	0.85	1.07	1.39	0.43
Preadipocyte - omental, donor2	11329-117E6	1243.94	55.00	59.80	0.87	1.75	1.31	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	561.10	40.25	32.52	2.86	1.00	0.43	0.43	0.29
Preadipocyte - perirenal, donor1	11469-119C2	1519.71	50.20	136.81	1.97	0.98	1.97	1.97	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	2659.64	217.13	141.89	0.92	0.31	0.31	1.54	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	1338.35	112.44	58.08	7.97	0.71	1.77	1.59	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	898.76	86.50	40.87	4.26	1.19	1.70	1.19	0.51
Preadipocyte - visceral, donor1	11280-116I2	1775.76	134.78	76.01	1.40	1.40	1.02	0.65	0.47
Preadipocyte - visceral, donor2	11357-117H7	822.34	63.97	44.18	3.22	0.46	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	1179.80	89.55	56.63	7.63	0.52	2.30	1.57	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	825.16	41.79	18.55	2.11	1.36	0.75	1.66	0.45
Prostate Epithelial Cells, donor2	11331-117E8	1051.49	37.78	153.69	6.09	0.68	1.76	3.93	0.95
Prostate Epithelial Cells, donor3	11404-118D9	179.73	15.43	8.70	0.67	0.98	0.18	0.31	0.06
Prostate Stromal Cells, donor1	11254-116F3	1766.25	111.62	73.12	3.76	1.14	0.80	1.94	0.68
Prostate Stromal Cells, donor2	11332-117E9	1000.31	80.33	43.21	6.63	0.54	1.08	0.54	1.08
Prostate Stromal Cells, donor3	11405-118E1	405.42	41.61	19.40	2.71	0.52	1.15	1.56	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	1680.38	150.01	63.51	1.09	1.09	0.36	0.36	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	1749.08	114.99	140.77	1.80	0.35	1.32	1.66	0.69
Renal Epithelial Cells, donor1	11517-119H5	2897.81	241.95	104.49	2.54	3.55	1.01	0.51	3.04
Renal Epithelial Cells, donor2	11597-120H4	1852.28	162.89	89.63	3.56	1.42	1.42	0.00	2.85
Renal Epithelial Cells, donor3	11678-122H4	1452.04	102.58	99.51	1.06	0.53	1.16	1.27	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	912.34	49.70	58.55	3.40	0.68	2.04	0.00	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1420.15	62.93	105.25	5.93	0.54	0.54	0.54	2.83
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1039.01	53.95	48.84	4.44	0.00	2.00	0.89	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	529.69	39.93	19.96	2.66	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	1923.79	145.48	76.59	1.32	0.88	0.66	0.44	0.88
Renal Mesangial Cells, donor2	11598-120H5	1236.41	107.84	61.44	3.76	0.63	0.63	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	973.71	99.59	39.95	1.11	1.11	1.66	1.39	2.77
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3408.70	207.76	153.00	1.34	1.61	0.54	1.88	3.22
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1558.58	113.86	80.12	5.06	1.27	1.69	0.84	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1773.61	165.85	72.12	4.82	1.35	0.77	1.93	3.28
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2103.03	176.05	115.90	1.81	1.30	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	1155.45	99.77	46.05	0.57	0.57	1.14	0.85	3.70
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1606.46	116.29	60.72	4.12	1.03	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	860.11	82.05	38.89	0.50	1.00	1.00	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	420.82	30.87	8.02	0.53	0.67	0.27	0.13	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	861.24	49.14	29.48	2.68	2.68	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1626.89	100.72	58.89	3.85	1.65	0.00	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1140.97	72.51	42.92	1.74	4.06	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	3063.00	171.37	70.73	2.73	3.51	0.65	0.26	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1780.45	128.90	50.94	8.94	2.58	1.69	1.59	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	2569.19	184.04	62.46	2.79	4.35	1.90	1.12	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	3188.78	235.06	81.25	9.18	3.23	0.74	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	1977.89	146.03	54.08	9.79	3.85	2.80	3.96	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1996.05	141.68	51.54	10.17	2.77	2.08	2.31	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1725.73	86.94	52.16	4.79	2.05	0.41	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	2074.56	137.51	47.80	14.37	3.18	1.82	1.51	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2261.74	167.90	47.49	1.08	3.40	1.43	0.72	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1949.86	91.53	61.69	5.59	3.30	1.43	1.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	2013.75	145.41	50.22	10.95	3.00	2.25	3.11	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	1782.99	138.96	47.35	5.31	2.43	2.21	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1857.66	60.79	56.78	5.16	3.25	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1766.18	137.51	46.30	6.24	2.52	1.02	1.02	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	2244.55	165.55	54.87	0.75	3.57	2.25	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1779.47	94.62	49.63	3.85	2.52	0.53	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1622.58	126.64	39.81	9.83	2.73	0.97	1.17	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	1760.45	128.90	50.41	3.44	2.10	2.10	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1897.29	101.35	51.47	7.37	3.63	0.53	0.75	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1958.21	133.15	48.49	10.93	3.36	2.24	2.52	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1556.03	114.33	37.08	5.98	2.22	1.54	1.03	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1753.84	79.68	51.23	3.83	4.01	1.09	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1689.75	124.35	40.96	10.30	3.07	1.84	2.08	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	1695.25	145.07	44.86	8.73	3.49	1.88	2.55	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	2411.09	75.95	79.96	7.31	3.77	1.18	0.71	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1877.19	139.09	44.05	10.91	2.18	1.98	2.58	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1973.19	143.58	44.20	7.95	3.74	1.40	1.40	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	2085.79	90.41	64.07	3.94	4.15	1.66	1.87	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	2484.41	150.42	68.58	32.08	2.65	2.65	4.42	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1539.06	118.02	39.48	4.39	3.97	1.67	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	1974.22	97.44	61.10	5.79	3.50	0.27	0.67	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1564.50	124.14	41.38	4.09	2.21	1.53	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1434.59	115.29	38.56	3.08	3.08	1.93	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2150.25	76.17	71.01	5.50	4.30	1.38	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1616.12	133.33	44.17	3.98	3.29	1.10	1.37	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	1706.87	123.95	47.44	12.97	2.13	2.46	1.64	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1489.73	52.66	36.47	4.43	1.87	0.85	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1518.64	116.89	35.07	3.55	2.81	0.89	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1085.13	78.37	30.12	1.87	2.67	0.53	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1224.35	76.18	34.15	2.90	1.94	0.28	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1622.90	129.77	39.52	5.00	4.76	1.67	1.67	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1551.06	87.87	53.61	3.43	3.02	1.21	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2026.25	94.83	86.17	6.03	4.05	1.41	0.85	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	1379.28	112.49	45.77	9.08	4.89	2.45	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	818.09	75.86	25.69	2.12	3.32	0.91	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2919.90	124.59	164.24	7.22	3.06	1.22	1.96	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1492.06	103.78	49.78	0.87	1.31	0.73	0.29	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	1916.55	129.60	70.58	12.78	4.26	1.83	3.65	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2999.22	108.20	174.51	9.04	5.43	2.71	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1358.71	101.56	44.79	6.33	2.94	3.39	1.58	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	1422.52	112.63	42.83	3.89	3.89	1.80	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1366.83	97.41	35.54	4.72	4.60	1.42	0.35	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1491.98	117.61	49.52	4.06	2.56	2.77	1.49	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1599.20	115.99	45.67	3.61	4.21	4.81	0.00	1.20
Schwann Cells, donor1	11498-119F4	1569.08	145.76	59.99	7.52	0.38	0.75	1.13	3.39
Schwann Cells, donor2	11578-120F3	1081.97	71.45	57.84	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	758.90	68.79	33.52	8.54	0.00	1.53	1.53	1.31
Sebocyte, donor1	11220-116B5	1318.48	80.52	62.99	1.10	0.55	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	787.22	46.42	52.39	3.68	0.46	0.46	0.46	0.92
Sebocyte, donor3	11378-118B1	607.62	42.67	23.70	3.71	0.41	0.82	1.24	0.62
Sertoli Cells, donor1	11255-116F4	2968.62	122.59	296.53	8.28	0.00	3.31	6.63	1.66
Sertoli Cells, donor2	11333-117F1	1971.41	96.03	248.54	14.12	2.82	11.30	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	838.25	78.04	35.81	0.70	1.41	0.18	0.88	0.09
Skeletal Muscle Cells, donor2	11358-117H8	289.86	28.91	26.75	2.89	2.89	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	4338.20	328.56	329.40	25.08	2.51	5.85	4.18	4.18
Skeletal Muscle Cells, donor4	11451-119A2	1747.83	150.34	96.30	13.04	0.47	2.83	2.83	3.30
Skeletal Muscle Cells, donor5	11455-119A6	1381.50	141.36	87.40	9.81	0.74	1.78	0.74	3.42
Skeletal Muscle Cells, donor6	11459-119B1	1654.45	150.52	91.11	9.39	0.77	2.15	2.15	2.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	1199.58	125.25	69.43	2.02	0.76	1.64	0.88	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	924.05	102.59	55.65	6.99	0.29	1.14	1.28	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1294.79	128.28	61.61	5.95	0.60	1.98	1.88	2.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	842.86	63.95	43.05	0.25	1.18	0.42	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1932.45	205.55	98.43	8.69	2.17	1.45	0.72	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	936.22	85.45	52.43	10.18	0.28	0.96	1.51	0.69
Skin - palm, donor1	10286-104F7	241.75	34.92	18.80	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	638.61	20.47	128.59	3.60	0.29	5.91	3.75	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	987.19	25.35	205.29	0.82	0.00	4.91	3.27	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	717.30	30.12	119.18	2.34	1.04	5.32	5.06	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	1250.79	54.49	157.91	2.64	1.11	2.22	3.06	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	605.53	29.54	70.75	4.50	1.13	0.56	0.98	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1941.49	69.99	171.91	1.06	2.11	0.85	0.85	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	336.30	14.47	40.92	1.57	0.67	0.52	0.75	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1314.57	38.88	229.28	7.41	1.23	1.54	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1708.17	53.58	175.86	2.45	0.00	0.89	1.56	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1816.39	143.43	88.17	0.00	2.94	1.18	0.59	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	1747.16	90.83	129.06	1.55	0.22	0.88	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2159.10	145.70	115.77	2.36	1.18	1.18	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	1895.88	139.06	104.30	1.55	2.32	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	303.23	34.03	17.01	1.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	1813.18	144.52	123.63	1.46	0.80	0.93	0.67	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	985.03	74.03	74.48	8.87	1.33	0.89	2.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1689.49	85.78	180.27	6.53	1.15	0.64	1.02	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	900.91	83.68	33.86	0.33	0.00	0.98	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1042.50	73.83	37.21	1.18	0.89	0.89	0.59	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	611.31	39.01	32.74	2.99	1.00	0.14	0.57	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1738.50	138.11	58.24	1.63	0.49	0.33	1.30	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	472.48	27.70	22.53	1.52	0.30	0.61	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	2984.54	223.52	186.39	1.52	1.26	1.77	0.51	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	936.47	61.21	79.57	0.00	0.00	6.12	0.00	24.48
Smooth Muscle Cells - Carotid, donor3	11434-118H3	2830.03	159.74	277.04	33.38	2.38	4.29	0.95	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	895.17	78.75	29.79	1.77	0.74	0.29	0.29	1.77
Smooth Muscle Cells - Colonic, donor2	11320-117D6	592.34	41.97	20.23	7.53	0.65	0.65	1.72	2.37
Smooth Muscle Cells - Colonic, donor3	11396-118D1	773.23	78.19	31.28	5.67	0.31	1.15	0.94	2.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2015.62	142.92	130.24	0.77	1.39	0.77	0.00	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1483.16	99.16	173.54	15.09	1.08	2.16	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	994.59	74.12	51.70	4.48	0.90	2.09	0.30	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2173.01	183.67	63.16	1.71	0.68	1.71	0.68	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1307.20	81.67	137.35	1.73	0.24	1.02	0.94	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	980.75	73.57	80.11	2.21	1.41	1.01	1.81	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	728.85	38.91	58.25	4.10	0.68	1.37	2.05	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2167.68	105.67	220.99	21.74	1.81	3.62	1.81	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2336.64	210.35	102.79	2.91	1.32	2.12	1.06	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1060.75	77.50	41.15	1.46	0.53	0.40	0.53	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	605.81	47.46	32.18	3.26	0.75	0.88	2.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	388.61	54.28	16.49	0.76	0.25	0.25	1.27	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	1933.67	141.27	108.41	1.66	1.81	1.06	1.21	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	938.46	81.02	63.01	6.75	0.75	0.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	730.10	31.01	65.90	9.05	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3576.86	240.91	319.04	6.51	1.40	2.33	0.00	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1264.73	80.78	98.45	5.55	1.01	2.02	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	1104.71	60.49	124.10	8.15	1.88	1.88	1.88	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1041.35	101.48	65.78	2.06	0.59	1.18	0.59	2.95
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1583.00	165.28	53.82	0.25	0.17	0.42	0.00	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	387.74	46.25	16.35	1.40	0.00	0.93	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2934.49	167.23	218.47	2.59	1.01	0.43	0.43	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	2056.47	123.91	144.05	15.30	0.51	1.53	2.29	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2451.20	151.74	194.43	14.10	0.94	1.50	1.88	2.07
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1709.21	149.39	72.53	0.56	0.14	0.56	1.12	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	1398.26	87.39	68.12	1.34	0.84	1.17	0.75	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	399.04	46.19	18.57	2.38	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2537.63	160.74	202.58	5.38	0.98	0.98	0.49	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	907.43	54.57	62.09	1.99	0.44	0.22	0.88	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1633.76	127.27	64.37	3.51	0.29	1.76	1.46	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	320.70	19.82	12.24	1.17	0.97	0.58	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	743.64	33.59	56.59	3.44	0.53	1.85	1.32	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	434.06	31.62	22.32	1.12	0.00	0.00	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	464.62	16.53	26.23	1.08	0.72	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	402.00	28.39	19.87	1.70	0.57	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1397.84	67.75	59.87	5.12	0.00	1.97	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	784.71	34.54	60.95	3.56	0.51	1.27	1.52	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	454.82	27.15	42.73	3.99	0.40	1.20	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	288.01	20.48	13.38	1.67	0.00	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	341.48	22.92	12.38	0.92	0.46	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	1606.45	91.23	112.94	4.21	1.01	0.84	1.35	0.67
Synoviocyte, donor2	11368-117I9	789.18	36.37	57.16	6.03	2.68	2.01	1.68	0.17
Synoviocyte, donor3	11440-118H9	608.57	34.85	36.64	5.36	1.56	0.89	0.89	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	3103.78	184.74	107.91	0.71	2.14	1.07	0.36	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	2162.41	83.25	136.76	5.95	1.98	3.96	3.96	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	1527.28	122.72	60.20	2.55	0.93	1.39	0.93	2.55
Tracheal Epithelial Cells, donor1	11292-117A5	1782.22	141.07	108.60	0.65	0.93	1.08	0.57	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	2013.22	151.53	171.63	10.82	2.32	0.00	3.09	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	2370.25	121.98	249.11	25.20	2.29	2.29	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	414.84	34.57	7.50	0.62	1.48	0.49	0.37	0.12
Urethra, donor2	10319-105A4	107.91	21.58	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	1653.48	91.65	124.06	1.06	1.06	0.80	1.06	2.66
Urothelial Cells, donor2	11600-120H7	976.98	61.69	72.50	5.61	0.00	1.20	0.80	3.20
Urothelial Cells, donor3	11681-122H7	771.96	62.34	51.57	2.29	0.69	0.46	0.92	2.52
Urothelial cells, donor0	11216-116B1	552.11	53.72	18.28	0.45	0.00	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	565.90	48.94	17.80	0.00	0.00	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	570.41	22.87	18.58	0.00	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	225.89	21.22	4.79	1.37	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	402.19	27.89	6.54	0.69	0.69	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	488.64	33.12	13.94	0.00	0.00	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	472.72	28.11	12.49	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	538.74	30.29	13.77	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	217.27	23.74	8.22	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	928.29	66.24	41.57	2.71	1.36	0.86	0.62	0.62
Wilms' tumor cell line:HFWT	10597-108E3	92.40	14.08	1.76	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1515.30	124.02	42.74	2.23	0.84	0.84	0.56	2.51
achilles tendon, donor2	10292-104G4	394.71	16.53	33.06	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1432.09	103.77	51.50	2.29	0.51	0.76	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1853.91	186.20	72.44	1.16	0.23	0.23	0.93	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	2625.46	112.77	196.82	1.54	0.47	0.71	1.19	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1643.57	125.99	59.87	1.09	2.45	1.09	1.36	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1579.13	78.14	77.86	7.87	0.84	2.53	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2217.38	134.29	69.15	2.11	0.85	1.48	1.06	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1169.42	57.16	98.81	2.45	0.54	1.36	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1895.63	81.08	153.34	4.41	1.76	3.97	0.00	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1578.72	74.32	62.89	5.31	0.41	1.23	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1302.35	103.68	50.09	1.94	0.39	2.33	1.16	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1849.94	144.81	76.91	5.89	2.02	2.39	1.29	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1411.99	81.91	74.11	3.90	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1890.19	81.10	178.00	6.04	0.93	1.86	1.63	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1953.15	90.62	113.66	5.70	0.78	0.78	0.26	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1673.10	101.41	64.29	6.72	0.88	1.46	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1010.39	58.56	45.55	2.32	0.46	0.00	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1458.30	67.86	27.55	2.06	0.41	1.65	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	355.14	41.75	17.80	0.61	1.23	0.31	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1327.06	131.43	43.52	2.99	1.71	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1317.81	140.12	40.64	1.21	0.61	0.61	1.52	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1491.17	142.50	49.59	0.48	1.20	0.72	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1261.59	71.94	60.36	4.68	0.67	2.45	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1050.67	77.72	47.36	3.00	1.67	0.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	315.89	35.31	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1213.98	113.75	80.23	3.77	0.75	1.13	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	520.74	49.72	35.33	2.62	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	477.99	59.98	37.49	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	611.12	60.99	19.55	1.41	4.00	0.47	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	442.40	43.90	8.84	0.93	0.93	0.47	0.16	0.31
adipose, donor1	10184-103D4	1742.22	187.65	45.74	15.25	0.59	1.76	1.17	2.35
adipose, donor2	10185-103D5	672.75	99.76	64.07	2.84	2.03	1.62	0.81	0.41
adipose, donor3	10186-103D6	667.38	97.75	30.77	1.91	1.63	1.09	2.45	0.54
adipose, donor4	10187-103D7	1170.98	115.28	41.60	6.07	0.00	8.67	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	865.64	98.64	78.91	2.05	1.26	1.10	0.32	1.10
adrenal gland, adult, pool1	10081-102A9	120.04	50.93	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1941.33	148.61	66.97	1.47	3.60	1.20	0.67	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1374.53	77.53	61.10	3.57	1.07	1.07	1.07	1.43
amniotic membrane cells, donor1	12235-129G3	1570.08	128.21	45.21	3.71	2.32	1.39	1.39	1.16
amniotic membrane cells, donor2	12236-129G4	616.02	50.72	8.11	1.69	1.69	0.34	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	1473.89	122.85	33.58	8.54	2.36	1.18	0.59	0.59
amygdala - adult, donor10196	10167-103B5	521.75	48.62	21.34	1.19	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	574.03	41.57	11.15	2.84	1.82	0.41	0.41	0.41
amygdala, newborn, donor10223	10360-105E9	393.46	29.37	13.23	1.29	1.94	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	1261.58	52.21	88.11	0.89	1.02	0.51	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1992.45	75.45	122.89	5.52	0.44	1.99	0.88	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	551.50	70.82	10.69	1.34	1.67	0.33	0.00	0.33
aorta, adult, pool1	10052-101G7	344.21	40.01	4.71	1.57	0.20	0.39	0.39	0.00
appendix, adult	10189-103D9	315.54	29.11	13.20	1.55	0.39	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1820.45	130.35	192.60	2.06	4.13	0.69	0.69	0.69
artery, adult	10190-103E1	81.52	20.38	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	1063.04	110.10	24.34	0.87	1.16	0.14	0.87	0.29
b cell line:RPMI1788	10427-106D4	2080.48	180.23	177.25	1.34	0.15	0.59	1.49	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	2127.74	109.59	151.76	3.33	0.55	1.66	4.99	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	1345.38	81.37	71.35	1.89	1.09	0.60	0.99	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	1441.63	35.15	46.03	1.67	2.34	1.34	0.50	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	606.77	49.21	44.18	2.24	1.68	2.24	0.56	0.00
bladder, adult, pool1	10011-101C2	501.92	47.15	10.86	0.87	0.54	0.65	0.54	0.87
blood, adult, pool1	10053-101G8	254.68	42.08	11.07	4.43	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	1027.62	30.83	22.27	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	574.95	45.89	28.34	5.40	0.67	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	501.26	61.50	8.20	5.13	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	588.19	58.80	13.03	0.89	1.45	0.33	0.78	0.89
brain, fetal, pool1	10085-102B4	411.40	90.83	2.67	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	317.15	22.13	19.16	2.97	0.66	1.32	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	1435.09	41.07	77.51	0.75	5.49	0.37	0.12	0.12
breast, adult, donor1	10080-102A8	265.17	27.78	3.16	0.00	1.26	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1159.98	123.23	142.54	3.30	1.40	1.40	0.38	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2281.12	146.57	271.50	10.20	1.55	1.55	1.86	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2611.61	360.52	198.68	13.12	1.15	2.76	1.84	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	718.75	46.72	33.41	1.45	0.97	1.69	0.48	0.97
carcinoid cell line:NCI-H1770	10703-109H1	2314.64	200.76	177.25	7.05	7.52	2.82	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	571.08	32.49	27.02	1.31	1.97	0.77	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	2528.51	133.41	282.35	3.80	1.58	2.54	3.17	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	911.39	113.39	43.39	7.99	2.13	0.53	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	566.45	24.18	17.27	1.15	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	658.93	52.54	17.90	3.68	2.34	0.50	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	543.30	38.97	32.86	1.53	3.06	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	581.58	27.83	19.04	2.20	1.83	0.73	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	521.48	32.05	20.39	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	491.07	28.40	6.62	2.99	4.06	0.43	0.00	0.00
cerebellum, adult, pool1	10083-102B2	340.46	38.63	14.83	2.76	1.03	0.34	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	474.09	28.23	13.28	0.00	2.49	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	390.56	38.07	11.60	1.26	1.01	0.25	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	271.16	10.96	18.27	1.46	0.73	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	2516.77	211.36	103.38	1.73	5.75	0.29	1.29	0.43
cervical cancer cell line:ME-180	10553-107I4	901.50	44.58	29.99	0.17	1.66	0.33	0.33	0.00
cervix, adult, pool1	10013-101C4	327.46	44.52	8.19	0.52	0.63	0.21	0.21	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1835.92	95.73	65.77	3.07	0.84	0.98	0.70	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	463.72	26.13	27.43	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	666.49	68.35	38.90	1.49	0.99	0.87	0.99	0.12
choriocarcinoma cell line:SCH	10785-110H2	1047.67	56.31	62.96	2.09	1.72	0.62	0.25	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	552.39	61.67	41.03	0.47	1.66	0.47	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	1228.86	104.00	38.18	3.13	2.28	1.14	1.71	1.42
chorionic membrane cells, donor2	12239-129G7	611.50	59.26	12.13	1.29	0.89	0.50	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	1383.05	99.46	45.61	13.74	1.65	4.95	2.75	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2313.46	86.84	200.95	25.25	0.00	1.01	5.05	9.09
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1612.48	77.99	117.37	5.19	0.58	2.88	1.54	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	609.69	73.92	24.71	2.96	0.42	0.42	0.63	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1474.55	124.55	111.97	5.39	0.77	0.51	0.51	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1667.51	122.63	133.52	5.56	0.97	0.73	0.24	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1541.53	98.14	129.70	5.70	0.61	0.61	0.61	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	1959.01	254.12	55.36	0.88	0.88	1.47	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	1396.69	116.76	98.78	1.04	0.52	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	1770.14	155.89	103.09	16.46	1.14	5.26	5.49	2.06
clear cell carcinoma cell line:TEN	10636-108I6	1617.77	97.86	71.31	2.95	1.56	0.52	1.39	1.21
colon carcinoma cell line:CACO-2	10513-107D9	1339.32	95.36	24.53	0.92	2.38	0.55	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	825.54	122.77	18.62	0.38	4.56	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	329.64	26.18	7.14	3.57	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	393.28	37.72	4.23	0.47	0.94	0.35	0.00	0.35
colon, fetal, donor1	10070-101I7	462.87	29.66	20.39	3.09	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	252.09	13.75	9.17	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	2303.38	150.22	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	945.48	38.67	120.68	0.00	0.00	0.00	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1721.22	76.07	235.75	1.06	0.45	0.91	1.06	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	1918.03	78.54	240.28	1.55	0.85	0.14	0.99	0.42
corpus callosum, adult, pool1	10042-101F6	776.48	63.02	17.47	0.22	1.88	0.44	0.55	0.22
cruciate ligament, donor2	10295-104G7	426.31	22.69	24.31	1.62	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	133.23	20.87	2.41	0.00	0.80	0.00	0.80	0.00
diencephalon, adult	10193-103E4	381.10	34.80	7.20	0.72	1.68	0.72	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	778.61	53.96	29.62	8.27	0.92	1.84	1.38	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	2449.51	186.43	174.64	2.56	3.33	0.77	0.51	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1305.19	79.44	82.09	0.72	0.72	0.48	1.20	0.72
ductus deferens, adult	10196-103E7	165.45	21.93	3.49	1.00	1.99	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	226.12	28.80	5.76	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	342.08	31.63	9.56	7.36	0.00	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	900.20	80.77	32.37	0.83	0.99	0.66	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2461.01	142.13	227.18	4.00	7.33	5.55	3.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2795.08	211.21	136.13	1.86	1.43	1.58	1.43	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	432.25	24.66	16.03	1.85	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	507.95	36.02	28.45	2.72	1.21	0.00	0.61	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	550.50	28.71	22.85	0.62	3.40	0.00	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	474.16	15.76	18.39	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	940.89	41.23	44.58	0.67	1.34	0.00	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	683.80	79.56	24.65	1.63	3.99	0.54	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1305.80	77.67	65.45	9.49	1.45	1.13	1.29	1.45
epidermoid carcinoma cell line:A431	10426-106D3	1315.56	78.14	46.58	1.00	0.67	0.22	0.89	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1912.10	100.86	114.16	1.43	2.42	0.44	0.99	0.44
epididymis, adult	10197-103E8	177.71	25.33	7.54	0.63	1.26	0.84	0.42	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1498.41	85.16	78.59	1.60	0.89	0.71	0.35	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	929.23	16.52	183.25	2.36	0.79	0.79	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2040.58	105.36	107.98	11.53	4.98	1.44	1.83	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1610.94	76.67	86.51	6.10	5.12	1.28	1.08	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1863.84	103.40	95.67	11.09	5.27	1.46	2.91	0.56
esophagus, adult, pool1	10015-101C6	744.20	54.36	19.32	1.06	1.49	0.96	0.85	1.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	822.42	54.10	53.35	0.50	1.00	0.00	0.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	89.34	16.90	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	178.86	14.73	6.31	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	40.18	7.44	1.49	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	206.37	16.05	8.03	0.00	0.00	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	513.00	23.32	27.69	2.91	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	1373.63	81.61	74.24	9.92	1.27	0.76	1.53	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	1266.34	96.30	86.04	2.69	0.64	1.92	0.38	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1361.12	113.96	77.64	2.61	1.19	0.95	1.42	0.47
frontal lobe, adult, pool1	10040-101F4	640.25	82.94	16.61	0.38	2.81	0.28	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1549.59	85.27	55.25	2.70	1.80	0.30	0.90	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	816.80	56.60	23.77	0.46	1.19	0.37	0.37	0.09
gall bladder, adult	10198-103E9	241.92	27.76	4.59	2.17	0.72	0.48	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	564.23	52.61	12.88	0.54	0.54	1.61	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	382.83	43.33	11.20	0.37	1.12	1.12	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	1237.73	80.68	54.71	10.14	2.11	1.90	2.53	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	609.65	44.87	27.66	1.35	0.97	0.39	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	1110.30	128.05	52.47	0.16	3.44	0.16	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	668.11	89.69	48.51	0.92	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1285.30	52.77	68.77	9.37	0.69	0.69	1.83	0.69
giant cell carcinoma cell line:LU65	10487-107B1	2247.88	135.51	69.30	2.29	8.95	1.15	1.61	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	1468.73	109.73	127.78	1.40	0.98	1.12	1.40	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	664.95	49.14	22.70	2.00	1.75	1.25	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	595.74	25.65	17.63	0.84	0.42	0.32	0.42	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	674.39	27.95	19.52	0.42	0.98	0.14	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	2066.19	88.85	75.72	0.99	0.99	0.55	0.77	0.33
glioma cell line:GI-1	10413-106B8	690.31	48.62	30.75	0.29	0.88	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	478.17	42.28	8.75	0.00	0.73	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	535.79	39.54	8.06	1.95	3.42	0.24	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	201.27	28.75	5.48	2.74	1.37	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	412.48	26.65	13.32	1.60	0.53	0.00	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	283.87	22.02	14.68	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	2885.09	185.78	142.07	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	2508.76	125.44	109.76	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	923.51	60.48	48.32	6.40	0.00	0.96	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	1590.83	94.58	60.14	1.38	1.38	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	1335.66	74.99	50.76	3.66	2.29	1.37	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	1566.43	91.46	66.34	1.93	2.58	1.29	0.64	0.64
hIPS, biol_rep1	14380-156B6	2035.20	77.61	81.93	4.31	1.44	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	1554.18	90.53	58.98	2.06	0.69	1.37	0.69	0.69
hIPS, biol_rep3	14382-156B8	585.94	38.62	20.97	0.00	1.10	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	1284.71	88.21	194.82	6.03	0.86	1.72	1.72	1.15
heart - mitral valve, adult	10205-103F7	141.41	17.94	2.99	1.49	0.00	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	97.53	16.47	0.52	0.00	0.78	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	411.32	21.65	15.82	0.00	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	336.90	40.61	8.37	2.24	0.61	0.41	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	155.85	22.99	1.28	0.85	0.00	0.43	0.00	0.43
heart, adult, pool1	10016-101C7	233.89	27.37	2.99	0.00	0.23	0.46	0.00	0.00
heart, fetal, pool1	10046-101G1	527.16	51.24	10.78	0.31	0.62	0.41	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	609.95	38.57	25.30	1.54	0.00	0.31	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	730.15	57.08	22.59	2.38	5.95	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1577.55	85.74	67.95	8.84	1.55	0.77	1.33	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1648.87	102.20	65.78	12.38	1.34	0.97	1.70	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1777.42	94.99	87.31	8.79	0.91	1.11	1.31	0.51
hepatoma cell line:Li-7	10484-107A7	1288.99	34.03	17.57	1.45	0.78	0.44	0.89	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2744.77	182.11	121.50	3.92	2.21	0.40	0.70	1.11
hippocampus - adult, donor10196	10169-103B7	652.97	55.83	26.50	3.79	0.00	0.00	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	641.69	39.39	13.47	3.47	2.86	1.02	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	456.62	24.40	13.44	0.00	0.50	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	287.62	23.97	16.92	0.00	2.82	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3767.04	255.12	144.04	39.06	0.61	12.21	6.10	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1616.20	153.35	63.62	7.07	1.77	5.11	6.68	2.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1685.10	140.91	73.63	8.12	2.29	3.30	4.32	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	604.46	108.26	23.12	1.69	2.26	3.95	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	731.77	110.00	26.60	24.01	2.07	5.68	6.46	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	813.50	115.02	33.41	2.28	0.76	4.18	3.80	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	819.22	99.85	59.56	5.55	1.46	5.55	2.04	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	936.25	119.56	67.00	8.83	2.59	5.82	5.17	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	533.02	64.65	22.94	1.67	3.75	2.09	1.67	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	885.13	103.00	31.26	1.89	1.42	1.66	1.66	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	760.03	104.47	31.98	4.18	0.48	3.54	2.57	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	867.89	103.69	30.97	3.37	2.02	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1424.01	136.77	63.53	8.29	1.88	5.01	4.85	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1687.10	148.37	79.59	41.76	0.49	8.84	10.32	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3098.27	221.68	185.90	9.60	0.87	11.35	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	580.56	89.92	18.52	4.20	0.38	3.25	1.72	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	538.55	69.77	23.98	4.36	1.74	1.31	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	919.06	89.46	27.49	9.50	1.50	2.50	1.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	964.19	125.85	104.93	7.54	0.94	7.72	2.83	2.83
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1160.89	134.60	118.23	7.28	0.45	4.09	9.55	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	927.49	98.98	103.05	5.95	0.94	3.13	2.51	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	630.18	71.36	27.76	3.10	0.98	3.27	1.80	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	649.13	71.13	36.87	4.94	1.45	2.61	4.06	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	522.82	57.39	41.55	5.08	1.49	1.49	4.18	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1530.24	144.47	62.44	9.98	1.85	5.54	5.36	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1393.90	128.09	60.48	5.42	0.57	4.56	3.14	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2407.00	191.50	92.69	13.47	2.04	7.76	5.72	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	716.13	84.50	27.81	11.97	1.41	3.87	4.58	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	610.36	74.12	27.56	3.48	1.58	2.85	2.53	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	627.03	78.38	29.35	3.63	0.30	2.72	2.12	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1015.11	109.63	77.57	6.21	1.55	5.69	4.65	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1111.15	111.58	72.39	3.98	1.33	5.31	2.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	741.89	71.57	53.87	4.87	1.54	2.82	2.05	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	726.04	77.21	36.05	11.25	0.26	4.09	2.56	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	752.68	81.02	39.38	3.03	3.03	0.76	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	738.65	56.46	37.97	4.03	1.68	2.69	2.02	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1461.11	139.83	45.89	9.66	1.69	6.28	4.59	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1872.21	136.82	84.23	12.92	1.78	7.58	6.24	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1428.79	122.93	67.32	11.22	0.98	6.34	6.34	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	507.02	82.52	14.98	2.44	0.92	3.06	1.83	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4613.10	442.44	87.84	61.81	0.00	0.00	3.25	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	851.51	110.87	24.16	6.29	0.33	3.64	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1124.15	142.30	77.17	6.57	1.64	5.47	4.38	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	914.48	100.60	79.61	4.34	1.45	5.07	3.62	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	874.02	104.63	75.44	4.27	2.14	6.05	6.05	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	793.60	83.54	38.19	3.58	1.19	3.58	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1023.41	121.61	42.12	3.39	1.22	2.30	1.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	641.97	63.31	30.71	2.69	0.81	0.81	2.42	0.00
immature langerhans cells, donor1	11904-125F5	405.11	61.26	25.18	0.00	0.24	0.24	0.00	0.48
immature langerhans cells, donor2	11905-125F6	355.67	62.58	30.10	0.00	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	856.91	103.91	26.21	0.85	3.22	0.28	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	643.47	57.88	12.03	1.30	1.30	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	1413.10	55.97	40.45	2.20	2.00	0.90	0.40	0.50
kidney, fetal, pool1	10045-101F9	1007.35	74.63	34.59	0.57	0.85	0.35	0.21	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	1513.52	74.28	88.19	0.85	0.43	0.57	0.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1113.26	41.75	83.91	6.50	0.83	1.24	1.66	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	320.57	19.82	9.54	0.73	0.92	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	147.11	16.35	2.72	1.63	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	181.02	20.73	5.06	0.51	0.51	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	702.90	56.09	24.62	2.74	1.37	0.27	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	472.41	48.14	38.08	3.95	0.72	1.80	2.16	1.08
leiomyoma cell line:15242A	10570-108B3	584.24	45.65	49.46	4.89	0.00	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	730.15	61.19	43.71	10.44	0.24	2.19	1.94	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	990.50	76.19	25.40	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	452.72	24.05	19.87	4.18	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1211.75	107.43	64.34	2.48	0.35	1.42	0.47	0.00
liposarcoma cell line:KMLS-1	10782-110G8	1201.72	55.45	64.36	3.75	0.47	1.09	0.94	0.78
liposarcoma cell line:SW 872	10726-110A6	1379.22	32.04	98.32	2.19	1.58	0.37	1.10	0.37
liver, adult, pool1	10018-101C9	977.39	47.00	23.50	1.13	4.05	0.81	0.81	1.13
liver, fetal, pool1	10086-102B5	447.78	31.04	15.99	3.76	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	446.37	31.21	16.33	1.02	1.46	0.15	0.00	0.44
locus coeruleus, adult, donor10252	10165-103B3	566.02	38.94	16.24	2.40	2.58	0.18	0.37	0.55
locus coeruleus, adult, donor10258	10375-105G6	367.63	31.04	16.36	1.97	2.54	4.23	2.54	1.13
locus coeruleus, newborn, donor10223	10362-105F2	802.54	43.74	23.55	1.26	2.52	0.84	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	1358.90	66.43	84.56	0.55	0.83	0.28	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	614.95	46.19	26.89	0.00	4.83	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	1805.49	115.87	158.18	6.85	1.45	1.19	2.11	1.32
lung, adult, pool1	10019-101D1	597.02	33.78	12.29	0.24	0.83	0.95	0.83	1.18
lung, fetal, donor1	10068-101I5	465.78	33.11	17.98	0.00	0.00	0.29	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	198.87	22.45	5.04	1.83	0.92	0.00	0.92	0.00
lymph node, adult, donor1	10077-102A5	455.85	39.76	20.83	5.21	0.00	0.47	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	707.29	38.14	70.36	1.75	0.66	1.53	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1394.26	122.10	37.43	1.36	0.45	1.06	1.21	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1200.34	72.21	35.68	0.85	0.00	0.00	0.00	1.70
mature adipocyte, donor1	12231-129F8	386.27	60.38	5.77	0.00	0.89	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	482.92	48.98	4.98	0.21	0.42	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	621.82	63.53	6.64	1.19	1.66	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	459.31	48.43	5.26	0.79	2.63	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1840.55	198.23	86.25	1.67	4.05	0.71	0.95	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	432.04	43.99	6.77	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	512.91	35.31	8.46	2.02	2.39	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	499.09	50.19	18.74	2.22	1.27	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	878.99	69.94	22.60	5.12	0.85	0.43	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	435.04	50.63	14.51	9.96	2.03	0.68	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	456.28	27.80	9.97	1.70	1.70	0.00	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	471.93	28.89	21.19	1.93	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1578.90	186.60	57.41	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	284.99	25.84	13.64	0.72	2.15	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	616.53	31.15	14.93	2.60	0.65	0.00	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	515.19	38.55	9.75	1.86	2.32	0.46	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	815.78	67.18	28.32	0.33	3.27	0.33	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	479.46	25.69	14.23	1.04	1.04	0.69	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1067.87	142.37	31.00	6.20	0.89	1.33	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	1313.21	76.91	59.55	1.83	0.61	0.73	0.24	0.24
melanoma cell line:COLO 679	10514-107E1	1057.25	83.66	52.75	1.29	2.87	0.57	0.72	0.00
melanoma cell line:G-361	10465-106H6	1204.48	118.63	70.58	3.26	1.09	2.99	1.36	0.54
meningioma cell line:HKBMM	10691-109F7	537.83	40.70	22.61	8.32	0.72	1.27	1.09	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	618.57	52.87	28.20	9.69	0.88	3.52	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	1000.60	144.91	32.40	5.18	3.11	2.07	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	1571.01	131.65	88.84	6.44	1.07	1.69	0.61	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	968.35	65.44	55.81	3.64	0.18	0.36	0.73	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	1636.53	76.19	113.88	6.21	0.41	2.07	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1116.78	53.80	53.10	3.51	1.55	0.28	0.28	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1029.28	56.04	80.11	5.01	0.77	0.96	1.35	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	650.35	37.48	37.48	0.69	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	519.71	43.77	27.46	2.92	1.20	0.00	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	681.01	51.64	33.01	2.88	0.69	0.46	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	864.26	75.07	36.61	3.98	1.06	0.00	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	825.50	69.28	37.95	4.46	0.81	0.27	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	1148.63	77.53	67.15	4.98	0.71	0.28	0.71	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	404.78	32.61	33.92	0.00	1.32	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	1505.62	88.00	112.50	6.09	0.97	0.42	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	1371.90	96.35	119.04	4.54	0.70	2.44	1.05	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1291.95	75.95	120.25	7.15	0.20	1.63	1.22	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	631.56	45.65	58.59	1.08	0.00	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1334.40	61.86	132.00	5.90	0.72	0.83	0.83	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	976.94	31.01	126.99	3.19	0.46	1.60	1.37	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1938.35	104.47	161.95	11.75	1.68	1.26	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1038.74	82.04	64.41	4.93	0.00	1.05	0.75	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1390.51	69.32	102.06	5.60	1.14	1.05	1.31	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1016.12	52.28	78.42	3.68	0.37	1.10	1.84	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	815.55	45.79	76.69	1.43	0.00	0.57	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	1737.11	154.09	84.20	19.79	1.68	2.53	4.21	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	804.65	58.91	44.75	2.74	0.46	0.46	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	924.15	53.46	42.72	3.84	0.77	1.53	1.28	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	807.52	56.02	37.69	0.26	0.79	1.57	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	787.78	46.21	35.74	3.08	0.62	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	931.30	48.95	44.95	4.47	0.71	1.41	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	872.54	52.12	48.06	2.71	0.34	1.35	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	890.87	53.44	47.94	3.14	1.57	2.36	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	853.09	56.07	41.70	4.63	1.85	0.46	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1545.71	48.30	193.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	1156.55	61.14	48.45	3.75	2.31	1.73	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	832.16	46.85	42.84	0.67	1.34	0.67	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	853.73	52.40	37.49	2.64	0.96	1.20	0.96	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	815.46	46.93	27.13	8.07	0.73	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	795.51	43.30	47.66	2.01	2.01	1.01	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	861.33	44.21	47.49	2.05	0.82	0.41	2.46	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	897.78	51.98	45.96	2.58	0.43	1.29	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	1066.42	62.89	38.28	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	1012.34	36.15	46.48	5.16	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	963.64	52.94	51.97	4.55	0.97	1.62	1.95	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1108.70	69.84	46.56	10.18	1.45	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1007.52	61.30	46.91	2.67	1.60	1.60	0.53	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	810.41	58.88	42.52	5.72	0.82	0.00	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	764.61	54.42	32.65	2.72	1.17	1.17	1.17	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	854.18	56.67	41.97	6.30	0.00	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1044.13	46.69	44.71	1.99	1.99	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	834.26	81.04	47.67	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	847.35	46.25	40.32	2.37	1.78	1.78	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1033.25	79.20	52.39	3.66	1.22	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1027.99	27.05	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	960.21	58.90	43.70	3.80	1.27	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	577.37	33.11	38.63	2.76	1.03	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	653.36	34.39	19.34	0.00	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	518.93	43.91	27.94	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	533.80	27.55	37.88	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	467.37	26.89	24.86	2.44	2.04	1.22	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	493.35	30.98	23.83	3.18	2.38	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	419.74	33.01	11.79	1.18	2.95	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	407.09	29.92	16.52	2.49	1.87	0.31	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	462.49	37.43	20.05	2.67	1.34	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	638.64	43.76	34.30	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	603.48	35.95	30.82	7.70	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	586.51	44.75	26.85	5.51	2.07	2.07	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	814.45	63.34	22.76	5.44	0.99	1.98	2.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	667.30	57.20	26.92	1.12	2.24	1.12	5.61	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	800.80	60.43	24.81	5.09	2.54	1.91	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	765.67	63.67	19.75	2.42	2.01	2.01	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	907.12	76.32	19.63	2.18	4.36	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	789.38	69.69	11.40	2.53	0.00	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	469.12	39.45	10.32	0.00	0.00	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	591.99	45.19	18.08	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	462.91	41.18	15.65	4.12	0.82	0.82	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	752.63	46.63	18.65	0.79	0.60	0.00	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	577.92	31.80	17.52	0.97	1.62	0.65	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	494.03	32.60	11.20	1.02	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	447.98	23.99	12.38	0.00	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	1935.76	99.22	88.12	3.07	3.78	1.18	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	1147.48	41.24	42.86	0.70	1.85	0.70	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	1064.13	25.64	55.56	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1546.08	56.72	53.84	1.85	0.51	3.70	2.57	0.62
mesothelioma cell line:Mero-25	10850-111F4	703.56	30.18	32.23	1.82	0.23	1.36	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	1029.49	47.18	40.58	3.67	0.49	2.44	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	659.86	38.31	32.77	1.55	0.89	0.66	0.89	0.66
mesothelioma cell line:Mero-82	10853-111F7	1195.50	49.93	56.50	4.47	0.53	0.53	0.79	0.79
mesothelioma cell line:Mero-83	10854-111F8	658.75	26.55	44.26	1.53	0.68	0.85	0.85	0.51
mesothelioma cell line:Mero-84	10855-111F9	1338.69	40.44	77.60	3.29	0.76	1.52	1.01	1.26
mesothelioma cell line:Mero-95	10856-111G1	967.72	49.90	37.89	1.86	1.45	1.24	1.04	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	1173.78	53.84	61.46	1.99	0.83	1.33	0.50	0.50
mesothelioma cell line:NCI-H226	10846-111E9	1723.77	56.65	153.30	3.98	2.53	1.63	1.09	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	2070.37	79.60	106.93	4.27	3.07	2.22	1.54	0.51
mesothelioma cell line:NCI-H28	10845-111E8	1067.48	55.73	106.37	4.83	1.02	0.76	0.76	1.02
mesothelioma cell line:No36	10857-111G2	866.07	29.68	32.62	2.61	0.98	0.65	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	1421.96	57.44	63.67	1.90	1.90	3.79	0.54	1.08
migratory langerhans cells, donor1	11901-125F2	2876.92	110.36	87.13	3.65	0.00	1.73	1.34	0.77
migratory langerhans cells, donor2	11902-125F3	2391.26	88.53	82.79	1.71	0.85	1.83	1.95	0.85
migratory langerhans cells, donor3	11903-125F4	2007.13	86.33	76.10	1.44	0.72	1.08	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	729.35	27.75	15.67	8.81	0.65	1.96	3.92	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	2782.30	205.15	204.09	25.22	1.91	4.87	6.15	3.39
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	372.72	28.56	11.29	1.15	0.92	0.46	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	979.05	61.08	106.18	2.66	0.95	0.76	0.76	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2040.48	127.51	75.03	1.85	0.92	2.03	0.55	0.74
myeloma cell line:PCM6	10474-106I6	2244.11	101.80	87.37	2.17	0.99	0.20	2.17	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	703.10	46.67	23.34	2.03	1.01	1.01	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1159.77	83.75	39.42	1.57	2.94	0.20	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	326.81	36.21	8.47	0.33	1.56	0.11	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	365.64	39.93	13.24	0.59	1.32	0.22	0.37	0.00
nasal epithelial cells, donor2	12227-129F4	776.65	64.03	55.75	0.55	1.10	0.55	1.10	3.31
neuroblastoma cell line:CHP-134	10508-107D4	477.38	53.83	17.94	0.00	1.15	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	763.31	88.12	24.70	0.37	0.37	0.37	0.19	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	626.34	41.97	9.28	0.84	2.11	0.21	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	484.89	43.23	13.79	1.12	1.68	0.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	217.54	23.72	18.74	2.61	1.42	0.00	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1026.31	57.97	56.54	4.43	0.79	1.90	2.38	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	1318.65	89.16	51.32	0.81	1.21	0.60	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	584.90	36.87	27.34	1.27	1.91	0.64	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	1341.21	66.54	100.88	3.73	0.27	0.53	1.06	0.53
neutrophil PMN, donor1	12133-128D9	327.25	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	624.19	26.56	66.40	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	994.42	85.24	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2171.51	208.69	67.31	2.54	0.00	0.85	1.01	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	521.13	37.62	8.01	0.80	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	627.11	45.53	26.93	2.24	1.28	0.96	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	789.34	43.36	33.63	8.67	1.05	3.68	1.84	1.05
nucleus accumbens, adult, pool1	10037-101F1	798.84	81.74	23.15	0.47	1.50	0.37	0.19	0.09
occipital cortex - adult, donor10196	10172-103C1	356.45	26.78	4.12	2.06	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	560.88	37.84	6.98	1.61	2.68	0.54	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	280.24	32.39	13.83	0.73	0.73	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	521.65	52.48	11.55	0.52	1.05	1.31	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	220.56	51.06	4.72	1.72	0.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	626.87	74.82	14.43	0.16	2.44	0.16	0.39	0.08
olfactory region, adult	10195-103E6	474.19	41.84	15.86	2.87	0.38	0.38	0.00	0.19
optic nerve, donor1	10277-104E7	160.08	8.00	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	791.55	54.56	28.59	0.34	4.10	0.34	0.57	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1726.40	122.55	47.67	1.51	2.20	0.27	1.10	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	682.37	32.34	23.03	8.30	0.17	0.51	0.51	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	661.29	61.68	33.50	1.39	1.04	0.69	0.69	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	1180.57	48.50	82.90	2.94	0.59	0.29	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1645.36	148.56	82.22	0.00	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1197.71	53.23	26.93	0.42	2.33	0.64	0.64	0.21
ovary, adult, pool1	10020-101D2	406.01	48.04	7.16	0.09	0.52	0.44	0.26	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	1439.62	75.89	164.81	7.15	0.18	2.02	1.83	0.73
pancreas, adult, donor1	10049-101G4	162.73	40.45	2.82	1.88	1.88	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	897.87	62.90	41.93	3.07	2.24	1.12	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	1954.29	36.97	115.84	23.00	2.38	2.21	2.73	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	392.10	20.70	6.95	0.66	0.83	0.33	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	659.97	80.72	19.77	0.46	2.29	0.18	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	467.56	22.75	19.08	2.20	0.00	1.47	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	385.60	44.20	9.40	3.76	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	528.74	38.48	8.55	3.71	2.57	0.00	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	664.86	75.43	14.80	0.26	3.97	0.26	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	228.88	30.06	3.88	0.97	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	325.63	30.66	14.95	0.37	2.24	0.00	0.00	0.37
parotid gland, adult	10199-103F1	313.27	29.60	6.78	1.85	3.70	0.00	0.00	0.62
penis, adult	10200-103F2	211.62	22.56	6.45	3.22	0.00	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	550.93	31.24	26.59	2.42	1.67	0.00	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	930.12	49.39	40.65	2.91	1.46	1.89	0.73	0.44
pineal gland - adult, donor10196	10179-103C8	178.67	24.51	3.87	0.65	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	274.79	40.27	1.18	0.00	1.18	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	161.16	22.57	5.64	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	184.15	36.42	1.01	3.04	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	253.81	40.13	4.17	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	132.79	37.45	3.40	0.85	0.85	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	469.03	51.60	15.70	0.43	0.86	0.32	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	1535.22	146.86	111.77	5.56	0.53	1.32	1.99	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	3322.28	43.27	190.35	4.36	1.25	1.40	2.02	0.47
pons, adult, pool1	10033-101E6	688.71	80.65	26.68	0.26	2.84	0.26	0.17	0.26
postcentral gyrus, adult, pool1	10032-101E5	680.75	83.60	13.86	0.70	2.70	0.61	0.26	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	359.72	16.73	4.18	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	2401.50	170.75	115.67	0.00	0.00	11.02	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	2347.15	140.83	105.62	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	2734.65	137.80	242.82	4.08	4.52	1.31	1.17	0.87
prostate cancer cell line:PC-3	10439-106E7	1998.70	132.31	83.85	2.72	1.09	0.54	0.36	0.91
prostate, adult, pool1	10022-101D4	250.76	38.45	4.53	0.27	0.45	0.18	0.00	0.27
putamen, adult, donor10196	10176-103C5	746.67	67.04	30.69	3.78	1.42	0.47	0.47	0.94
putamen, adult, donor10252	10152-102I8	574.49	35.29	15.69	0.00	1.96	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	887.36	44.81	40.43	0.00	2.19	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	523.82	42.04	17.15	1.45	2.17	0.24	0.48	0.48
putamen, newborn, donor10223	10365-105F5	909.34	42.73	32.24	3.00	0.75	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	480.33	38.40	15.71	0.00	1.16	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	228.12	33.38	6.95	1.39	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	1866.01	119.14	56.18	1.91	2.54	1.48	1.70	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2380.47	108.52	223.67	6.21	0.00	2.49	4.56	1.66
retina, adult, pool1	10030-101E3	592.02	52.28	11.23	0.89	2.48	0.10	0.20	0.20
retinoblastoma cell line:Y79	10475-106I7	3031.37	257.20	233.82	1.04	1.82	1.04	1.30	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1123.50	65.16	45.86	2.09	1.23	0.98	0.25	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	937.52	115.57	34.31	0.84	1.69	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	235.69	25.77	9.09	0.76	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	859.94	41.60	84.49	2.59	1.29	0.49	0.81	0.16
salivary acinar cells, donor2	11772-123I8	733.05	43.92	47.36	4.13	2.07	1.38	1.51	0.55
salivary acinar cells, donor3	11773-123I9	273.43	13.90	9.93	0.66	1.32	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	1030.09	50.33	18.87	0.57	2.86	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	994.79	74.95	59.44	1.01	1.35	0.76	0.59	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1112.51	93.57	56.78	1.41	0.94	0.12	0.24	0.00
seminal vesicle, adult	10201-103F3	171.95	22.22	9.52	1.59	0.53	1.59	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1158.02	73.12	40.08	11.17	3.16	1.21	0.73	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2186.68	72.72	195.27	6.04	1.01	1.51	1.76	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	2504.82	141.50	172.61	4.01	0.00	1.00	2.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	613.58	34.52	23.24	1.34	1.34	0.81	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	1445.48	76.04	42.88	1.44	3.32	0.77	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	1017.49	56.26	73.93	1.16	1.68	0.65	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	69.51	14.19	0.71	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	318.31	36.46	6.00	0.24	0.12	0.12	0.00	0.48
skeletal muscle, fetal, donor1	10066-101I3	236.18	33.17	9.05	3.02	0.00	0.00	0.00	2.01
skin, adult, donor1	10074-102A2	298.55	27.14	13.57	6.79	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	301.73	35.35	6.31	0.63	1.89	1.89	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	741.42	132.74	26.35	1.00	7.00	0.67	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	571.78	48.54	23.01	3.15	2.52	0.63	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	804.34	163.84	25.64	5.59	1.73	0.96	0.96	1.54
small cell lung carcinoma cell line:LK-2	10541-107H1	1121.48	149.50	55.71	0.33	2.80	0.00	0.82	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2515.05	373.81	230.34	9.17	1.45	3.54	2.57	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	1393.58	89.13	73.66	3.49	3.05	0.44	1.31	0.00
small intestine, adult, pool1	10024-101D6	668.88	39.66	12.18	0.60	2.87	0.72	0.48	0.24
small intestine, fetal, donor1	10064-101I1	372.97	42.75	11.55	3.19	0.25	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	875.01	47.19	40.52	8.21	1.03	0.51	0.51	2.56
smooth muscle, adult, pool1	10048-101G3	217.88	31.01	2.07	1.81	0.52	0.00	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	274.99	23.59	12.60	0.54	0.80	0.54	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	387.01	33.26	9.18	5.51	0.23	0.46	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	603.63	43.37	8.28	0.79	1.97	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	774.81	37.36	13.84	2.08	0.00	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	491.53	53.67	6.10	2.44	0.00	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	852.30	50.05	22.96	3.67	0.46	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	1079.09	48.09	74.38	4.03	0.60	0.60	0.60	0.30
spleen, adult, pool1	10025-101D7	569.39	47.58	13.88	0.44	0.88	0.22	0.22	0.44
spleen, fetal, pool1	10044-101F8	625.23	56.10	21.06	0.40	0.56	0.40	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1931.85	167.07	88.09	1.76	0.41	1.76	1.24	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	406.90	30.38	9.11	0.38	0.76	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	573.45	52.42	17.47	6.64	1.75	0.70	1.05	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	327.99	19.16	13.68	1.95	0.00	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	2189.49	108.28	70.46	1.24	5.29	1.13	1.35	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	584.57	23.30	22.03	1.69	0.00	0.85	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	682.84	41.88	41.04	1.69	2.12	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	162.33	36.31	1.07	0.00	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	477.96	25.64	9.11	3.42	2.28	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	379.92	0.00	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	493.09	34.69	5.82	1.87	3.12	0.21	1.04	0.00
substantia nigra, adult, donor10258	10371-105G2	395.18	29.48	11.90	1.03	1.03	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	488.24	23.32	17.66	2.12	2.12	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	553.91	92.39	9.40	0.23	0.23	0.69	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	865.17	99.52	23.91	1.19	3.48	0.42	0.93	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	239.32	41.31	3.56	0.71	1.42	1.42	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	239.99	39.12	8.79	0.88	0.44	0.88	0.00	0.44
tenocyte, donor1	11763-123H8	930.35	45.38	44.34	9.77	0.35	1.75	1.40	3.49
tenocyte, donor2	11765-123I1	744.70	22.13	44.64	4.20	0.76	1.14	1.14	0.76
tenocyte, donor3	11768-123I4	783.96	42.26	44.48	8.90	1.11	1.11	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	5713.05	298.62	461.95	13.60	7.82	5.95	3.91	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	1257.23	65.51	35.61	3.70	1.54	2.00	1.70	0.31
teratocarcinoma cell line:PA-1	10807-111A6	1513.05	128.32	72.22	3.10	0.62	1.55	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1725.72	66.27	106.38	4.19	1.78	1.14	2.29	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	738.57	69.58	49.92	3.40	1.13	0.38	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3302.41	82.56	785.58	15.92	7.74	1.85	2.51	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2453.19	179.46	361.20	41.69	1.63	3.26	4.23	2.61
testis, adult, pool1	10026-101D8	276.48	72.15	10.52	0.43	20.83	1.29	0.64	0.86
testis, adult, pool2	10096-102C6	213.36	67.66	11.28	1.35	22.10	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	442.70	30.91	8.83	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	491.67	32.51	8.44	1.41	2.34	0.47	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	726.70	18.48	24.63	0.00	7.70	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	176.71	21.08	5.76	0.82	1.32	1.15	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	424.01	32.22	17.83	1.73	2.30	0.58	1.15	0.58
throat, adult	10209-103G2	350.29	27.96	7.99	1.75	1.00	0.25	0.75	0.25
throat, fetal, donor1	10061-101H7	170.03	30.47	3.35	1.52	0.00	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	1519.70	142.29	36.57	1.59	1.79	0.99	0.79	0.00
thymus, adult, pool1	10027-101D9	761.22	79.43	30.12	1.19	0.30	0.80	0.80	0.99
thymus, fetal, pool1	10043-101F7	720.06	56.11	31.17	0.21	0.52	0.42	0.21	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	2346.76	89.75	145.19	5.32	0.66	1.73	1.46	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	2165.06	102.53	166.79	6.29	1.12	1.40	1.26	0.56
thyroid, adult, pool1	10028-101E1	454.34	53.65	7.19	0.37	2.05	0.56	0.56	1.21
thyroid, fetal, donor1	10060-101H6	162.15	34.28	2.64	1.58	1.58	0.00	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	289.48	9.24	18.48	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	584.93	46.75	25.35	5.12	0.23	1.16	1.16	0.47
tongue, fetal, donor1	10059-101H5	267.19	33.50	6.31	4.34	0.00	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	924.02	81.24	30.45	0.80	1.60	0.10	0.50	0.10
trachea, adult, pool1	10029-101E2	829.19	56.28	25.77	0.82	1.23	0.49	0.25	0.00
trachea, fetal, donor1	10058-101H4	325.45	34.62	12.69	2.69	0.77	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	947.69	60.94	40.74	4.96	0.00	1.06	1.77	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	1263.92	93.31	31.71	1.22	1.62	0.10	0.81	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	2094.12	212.47	190.84	3.76	2.04	1.57	2.19	1.41
tridermal teratoma cell line:HGRT	10694-109G1	566.95	26.64	15.22	1.90	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	430.36	48.93	13.97	0.93	0.59	0.17	0.08	0.25
umbilical cord, fetal, donor1	10057-101H3	402.69	29.21	18.78	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	321.29	46.75	4.61	0.00	0.17	0.00	0.17	0.00
uterus, fetal, donor1	10055-101H1	672.67	74.23	26.11	3.58	0.51	0.00	0.51	0.00
vagina, adult	10204-103F6	199.03	16.15	4.52	0.00	2.58	0.00	0.00	0.00
vein, adult	10191-103E2	201.00	24.33	7.89	1.10	0.44	0.66	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1021.95	84.92	114.56	3.47	0.00	0.80	1.07	0.80